{
    "testId": 375996148,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 23,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 24,
    "correctToIncorrect": 0,
    "incorrectToCorrect": 2,
    "incorrectToIncorrect": 1,
    "timeInSeconds": 2739,
    "averageTimeSpentInSeconds": 201,
    "otherAverageTimeSpentInSeconds": 78,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 40,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 19076,
            "questionIndex": 20560,
            "questionText": "<p>A study is conducted to evaluate the amino acid phenylalanine in preterm newborns who were fed different human milk diets.&nbsp; Twenty-four very low-birth-weight, preterm newborns were randomly assigned to one of the following feeding groups:</p><ul><li><p>Group I: banked human milk plus 5% commercial fortifier with bovine protein</p></li><li><p>Group II: banked human milk plus evaporated fortifier derived from modified human milk</p></li><li><p>Group III: banked human milk plus lyophilized fortifier derived from modified human milk</p></li></ul><p>The newborns received one of the group diets until full diet was attained at 15 days.&nbsp; Plasma amino acid analysis was performed on the first and last day of feeding.&nbsp; Analysis of data includes an analysis of variance (ANOVA) to compare group mean levels of phenylalanine in plasma at Day 0 and at Day 15, along with 95% confidence intervals to estimate ANOVA-adjusted means for each group at each time point.&nbsp; An excerpt of results is shown below:</p><p><img  draggable=\"false\" id=\"41578\" src=\"https://www.uworld.com/media/highresdefault/L67601.png\"  ></p><p>Based on these findings, which of the following statements is most accurate?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Analysis of variance (ANOVA)</strong> compares the <a href=\"33900\">means of &#8805;3 independent groups</a>.&nbsp; The null (H<font size=\"2\"><sub>0</sub></font>) and alternative (H<font size=\"2\"><sub>a</sub></font>) hypotheses of interest in an ANOVA are:</p><ul><li><p>H<font size=\"2\"><sub>0</sub></font>: &#956;<font size=\"2\"><sub>1</sub></font> = &#956;<font size=\"2\"><sub>2</sub></font> = &#956;<font size=\"2\"><sub>3</sub></font> ... = &#956;<font size=\"2\"><sub>k</sub></font> (ie, all means are equal)</p></li><li><p>H<font size=\"2\"><sub>a</sub></font>: All means are not equal</p></li></ul><p>Therefore, an ANOVA that is <strong>not statistically significant</strong> (eg, <em>p</em> &#8805; 0.05) indicates that all group <strong>means are equal</strong> whereas an ANOVA that is <strong>statistically significant</strong> (eg, <em>p</em> &lt; 0.05) indicates only that <strong>at least 1 group mean is different</strong> from the rest.&nbsp; However, an ANOVA does not determine which group means differ&mdash;further evaluation is required to determine the specific difference.</p><p>In this question, ANOVA is used to determine whether the mean levels of phenylalanine in preterm newborn plasma differ among 3 feeding groups.&nbsp; The ANOVA test at Day 0 shows no evidence of a significant difference among group means (<em>p</em> = 0.93) <strong>(Choice A)</strong>, but the ANOVA test at Day 15 shows evidence of a significant difference among group means (<em>p</em> = 0.01) <strong>(Choice D)</strong>.&nbsp; This does not mean that each group has a mean plasma phenylalanine level that is statistically significantly different from the other 2 group means <strong>(Choice B)</strong>; instead, it means that the group means are not all the same at Day 15.</p><p><strong>(Choice C)</strong>&nbsp; The study does not directly compare the mean plasma phenylalanine level at Day 0 to the mean plasma phenylalanine level at Day 15 (ie, pre-post comparison).&nbsp; Therefore, it is not possible to determine whether there is a significant increase in mean plasma phenylalanine levels in all 3 groups from Day 0 to Day 15.</p><p><strong>Educational objective:</strong><br>Analysis of variance (ANOVA) compares the means of independent groups and determines only whether at least 1 group mean differs from the others.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 15780,
            "topic": "Statistical tests",
            "titleId": 15780,
            "title": "Statistical tests",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "At Day 0, there is a statistically significant difference in mean plasma phenylalanine levels among groups",
                    "choiceNumber": 1,
                    "correctTaken": 69,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "At Day 15, each group has a mean plasma phenylalanine level that is statistically significantly different from that of the other 2 group means",
                    "choiceNumber": 2,
                    "correctTaken": 2404,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is evidence of a significant increase in mean plasma phenylalanine levels in all 3 groups from Day 0 to Day 15",
                    "choiceNumber": 3,
                    "correctTaken": 1035,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is no statistically significant difference in mean plasma phenylalanine level among groups at either Day 0 or Day 15",
                    "choiceNumber": 4,
                    "correctTaken": 258,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The mean plasma phenylalanine levels of Groups I, II, and III are not all the same at Day 15",
                    "choiceNumber": 5,
                    "correctTaken": 7752,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "513,643,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 183,
            "othersAvgTimeSpent": 109,
            "notes": null,
            "peopleTaken": 11518,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 981,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 4019,
            "questionIndex": 4019,
            "questionText": "<p>Two studies were conducted on different samples from the same population to assess the relationship between oral contraceptive use and the risk of deep venous thrombosis (DVT).&nbsp; Study A showed an increased risk of DVT among oral contraceptive users, with a relative risk of 2.0 and a 95% confidence interval of 1.2-2.8.&nbsp; Study B showed a relative risk of 2.01 and a 95% confidence interval of 0.8-3.1.&nbsp; Which of the following statements is most likely to be true regarding these 2 studies?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t76367\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\">Statistical significance:<br />Relationship between confidence intervals and <em>p</em>-values</p></td></tr><tr><td><p>&quot;A ___ confidence interval that does not include the null value&hellip;&quot;</p></td><td><p align=\"center\">95%</p></td><td><p align=\"center\">99%</p></td></tr><tr><td><p>&quot;&hellip;corresponds to <em>p</em> &lt; ___.&quot;</p></td><td><p align=\"center\">0.05</p></td><td><p align=\"center\">0.01</p></td></tr></tbody></table></div></p><p>The <strong>relative risk (RR)</strong> is the risk of an outcome (eg, deep venous thrombosis [DVT]) in the exposed group (eg, oral contraceptive [OC] users) divided by the risk of that outcome in the unexposed group.&nbsp; If the RR = 1.0 (<strong>null value</strong>), then there is no association between exposure and outcome (or disease).&nbsp; An RR &gt;1.0 indicates that exposure is associated with increased risk of disease.&nbsp; An RR &lt;1.0 means that exposure is associated with decreased risk of disease.&nbsp; The RR in studies A and B was &gt;1.0, suggesting increased DVT risk among OC users.</p><p>For a result to be considered statistically significant, its corresponding confidence interval (CI) must NOT contain the null value.&nbsp; When the <strong>95% CI</strong> does <strong>not</strong> include the null value, this gives a corresponding <strong>p-value &lt;0.05</strong> and the association between exposure and outcome is considered <strong>statistically significant</strong>.&nbsp; A p-value &lt;0.05 reflects that there is a very low probability that the result was due to chance alone; formally, the p-value is the probability of observing a given (or more extreme) result due to chance alone, assuming that the null hypothesis is true.&nbsp; The RR obtained in study A (RR = 2.0)&nbsp;is statistically significant as its 95% confidence interval (1.2-2.8) does not include the null value (because it does not include 1.0) <strong>(Choice C)</strong>.&nbsp; The 95% confidence interval for study B (0.8-3.1) includes the null value of 1.0, and thus the study is not statistically significant; in other words, the corresponding p-value would be &gt;0.05 <strong>(Choice A)</strong>.</p><p>The CI in study B is wider than in study A, and it contains the null value (ie, not statistically significant).&nbsp; This wider CI is most likely due to a <strong>smaller sample size</strong>, which decreases the study&#39;s <strong>power</strong> (ie, its ability to detect the difference between exposed and unexposed subjects).&nbsp; Increasing sample size would increase the study&#39;s power and make the CI narrower.&nbsp; By doing so, the null value would likely have been excluded (as in study A), thus increasing statistical significance.&nbsp; Although there are several causes of a wide CI, small sample size is a common one.</p><p><strong>(Choices B and D)</strong>&nbsp; Measurements that lack accuracy (proximity to the true value) generally reflect a bias (systematic deviation from the true value).&nbsp; The accuracy of the studies cannot be judged because there is no information on how they were designed and conducted.</p><p><strong>Educational objective:</strong><br>The power of a study represents its ability to detect a difference between 2 groups (eg, exposed versus unexposed) when there truly is a difference.&nbsp; Increasing the sample size increases the power of a study and consequently narrows the confidence interval surrounding the point estimate.&nbsp; Confidence intervals express statistical significance and are interrelated with p-values.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 8373,
            "topic": "P-value and confidence interval",
            "titleId": 8373,
            "title": "P-value and confidence interval",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "The p-value in study B is likely &lt;0.05",
                    "choiceNumber": 1,
                    "correctTaken": 10891,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The result in study A is not accurate",
                    "choiceNumber": 2,
                    "correctTaken": 1188,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The result in study A is not statistically significant",
                    "choiceNumber": 3,
                    "correctTaken": 5318,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The result in study B is likely biased",
                    "choiceNumber": 4,
                    "correctTaken": 8444,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The sample size is likely smaller in study B than study A",
                    "choiceNumber": 5,
                    "correctTaken": 72478,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1845,1937,true,-1,1*2022,2103,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 137,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 98319,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 656,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 20035,
            "questionIndex": 21528,
            "questionText": "<p>The neurorehabilitation unit at a local hospital conducted a randomized controlled trial to compare the effects of high-intensity treadmill training (HITT) against low-intensity treadmill training (LITT) on gait ability, quality of life, cardiorespiratory fitness, and cost of walking in patients with chronic stroke.&nbsp; Thirty patients were randomized to either HITT or LITT, but 9 patients in the HITT group and 3 patients in the LITT group dropped out of the study.&nbsp; The statistical analysis was conducted following a per-protocol principle.&nbsp; Based on this information, which of the following is of most concern regarding the analysis?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"42545\" src=\"https://www.uworld.com/media/L68081.png\" ></p><p>Study <strong>dropouts</strong> may bias estimates of treatment effect.&nbsp; For example, in a placebo-controlled, randomized trial of interventions (ie, high-intensity treadmill training [HITT] group vs low-intensity treadmill training [LITT] group), adverse effects on health may cause a greater proportion of patients with more severe illness to drop out from the HITT group than from the LITT group.&nbsp; This means that at the trial&#39;s conclusion, the HITT group may have a smaller proportion of more severely ill patients than the LITT group (eg, selection bias).&nbsp; This could distort the estimation of the effect of the interventions (eg, confounding bias).</p><p><strong>Per-protocol (PP)</strong> analysis compares treatment groups in a randomized trial by including in the analysis only those participants who <strong>strictly adhered</strong> to and completed the protocol (ie, it <strong>excludes dropouts</strong>).&nbsp; Therefore, it provides an estimate of the effect of an intervention assuming an (unrealistic) <strong>perfect scenario</strong> in which all participants were retained and completed treatments as planned <strong>(Choice C)</strong>.&nbsp; However, <strong>clinical settings</strong> (eg, medical practices) almost inevitably include dropouts, so PP analysis <strong>misrepresents</strong> (typically overestimates) the effect of the intervention.</p><p>In contrast, an <strong>intention-to-treat (ITT)</strong> analysis includes all participants as initially allocated after randomization, regardless of what happens during the study period (eg, keeping the HITT and LITT dropouts in their respective groups for analysis).&nbsp; ITT analysis estimates the effect of assigning (rather than receiving) an intervention; compared to PP analysis, ITT analysis could lead to a more <strong>conservative</strong> estimate of the effect of the intervention <strong>(Choices D and E)</strong>.&nbsp; However, it closely mirrors the expected number of dropouts in a real-life situation, so ITT analysis reflects the (realistic) expected effect of the intervention in a medical practice setting.</p><p><strong>(Choice A)</strong>&nbsp; Participants drop out of a study before any statistical analysis is conducted, so the type of statistical analysis does not affect the dropout rates in a study.</p><p><strong>Educational objective:</strong><br>Per-protocol analysis includes only those participants who strictly adhered to and completed the study protocol (ie, nondropouts).&nbsp; This approach tends to provide an estimate of the true effect of an intervention for a perfect scenario, but it can overestimate the effect of the intervention in a practical clinical setting.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 30907,
            "topic": "Per-treatment analysis",
            "titleId": 30907,
            "title": "Per-treatment analysis",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "It will increase the chance of differential dropouts between intervention groups",
                    "choiceNumber": 1,
                    "correctTaken": 846,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "It will misrepresent the effect of the intervention among patients of a medical practice",
                    "choiceNumber": 2,
                    "correctTaken": 5058,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "It will not estimate the effect of the intervention in patients who completed the study",
                    "choiceNumber": 3,
                    "correctTaken": 734,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "It will only estimate the effect of assigning the intervention to patients",
                    "choiceNumber": 4,
                    "correctTaken": 1312,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "It will result in a more conservative estimate of the effect of the intervention",
                    "choiceNumber": 5,
                    "correctTaken": 2632,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "416,669,true,-1,1*1086,1250,true,-1,1*1505,1708,true,-1,1*1817,1922,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 89,
            "othersAvgTimeSpent": 84,
            "notes": null,
            "peopleTaken": 10582,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 859,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 4686,
            "questionIndex": 4686,
            "questionText": "<p>In recent years, more people have been diagnosed with leukemia in town A than in town B.&nbsp; Which of the following study designs would be best suited to determine whether the town location is related to the apparent difference in leukemia incidence in these 2 towns?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"6804\" src=\"https://www.uworld.com/media/L13767.jpg\" ></p><p><strong>Incidence</strong> is defined as the number of new cases of a disease arising in an at-risk population over a specified time period.&nbsp; Subjects without the disease are followed over a period of time to discover how many eventually develop that disease.&nbsp; A <strong>cohort</strong> study is an observational study in which groups are chosen based upon presence or absence of one or more risk factors.&nbsp; All subjects are observed over time for development of the disease of interest, allowing for estimation of incidence within the total population and comparison of incidences between groups.</p><p>In this example, the town of residence is the risk factor of interest and leukemia is the disease of interest.&nbsp; Residents of town A and town B could be followed for a period of time and the incidence of leukemia determined for each site.&nbsp; Comparing the incidences between the 2 towns would allow determination of the relative risk for developing leukemia in town A compared to town B.&nbsp; This would be an example of a prospective cohort study; retrospective cohort studies review prior records to determine incidence of a disease of interest in groups of subjects chosen based on presence or absence of a risk factor.</p><p><strong>(Choice A)</strong>&nbsp; In a case-control study, subjects with the disease of interest (cases) are compared to an otherwise similar group of disease-free subjects (controls).&nbsp; Information is then collected about exposure to risk factors.&nbsp; A case-control study is retrospective and meant to determine associations between risk factors and disease occurrence.&nbsp; An odds ratio can be calculated in a case-control study, but the incidence of a disease cannot.</p><p><strong>(Choice B)</strong>&nbsp; A case series is a study involving only patients already diagnosed with a condition of interest.&nbsp; A case series can be helpful in determining the natural history of uncommon conditions, but it provides no information about disease incidence.</p><p><strong>(Choice C)</strong>&nbsp; A clinical trial compares the therapeutic benefit of different interventions in patients already diagnosed with a particular disease.&nbsp; Clinical trials cannot be used to determine disease incidence.</p><p><strong>(Choice E)</strong>&nbsp; In ecological studies, the unit of observation is a population.&nbsp; Disease rates and exposures are measured in 2 (or more) populations, and the association between disease rates and exposures is determined.&nbsp; However, results about associations at the population level may not translate to the individual level.&nbsp; Ecological studies cannot be used to determine incidence.</p><p><strong>Educational objective:</strong><br>A cohort study design is best for determining the incidence of a disease.&nbsp; Comparing the incidence of the disease in 2 populations, with and without a given risk factor, allows for calculation of relative risk.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 15391,
            "topic": "Risk, rate, prevalence and incidence",
            "titleId": 15391,
            "title": "Risk, rate, prevalence and incidence",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Case control",
                    "choiceNumber": 1,
                    "correctTaken": 3262,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Case series",
                    "choiceNumber": 2,
                    "correctTaken": 513,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Clinical trial",
                    "choiceNumber": 3,
                    "correctTaken": 85,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cohort",
                    "choiceNumber": 4,
                    "correctTaken": 4984,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ecological",
                    "choiceNumber": 5,
                    "correctTaken": 5305,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2130,2497,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 73,
            "othersAvgTimeSpent": 30,
            "notes": null,
            "peopleTaken": 14149,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 35,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1097,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 18854,
            "questionIndex": 20331,
            "questionText": "<p>A 68-year-old man with severe knee osteoarthritis comes to the office to discuss options for total knee arthroplasty (TKA).&nbsp; The patient wants to know which type of prosthesis will help him return to his active lifestyle.&nbsp; A recent study compared the 10-year clinical, radiologic, and survival outcomes of single-radius (SR) prostheses and multiradius (MR) posterior-stabilized prostheses in TKA.&nbsp; In terms of clinical outcomes, the study reported that health survey scores were all significantly improved in both groups at the final follow-up visit (<em>p</em> &lt; 0.05), with no significant differences between the 2 groups (<em>p</em> &gt; 0.05).&nbsp; The SR group had significantly less anterior knee pain and painless crepitation (<em>p</em> &lt; 0.05) compared to the MR group.&nbsp; Radiologic results in terms of radiolucent lines and component position angle showed no differences between the groups (<em>p</em> &gt; 0.05).&nbsp; The Kaplan-Meier survival curve estimates at 10 years are shown below.</p><p><img draggable=\"false\" id=\"40274\" src=\"https://www.uworld.com/media/L66333.png\" ></p><p>Based on the findings of this study, which of the following conclusions is justified?</p>",
            "questionHeader": "",
            "explanationText": "<p>The <strong>Kaplan-Meier (KM)</strong> statistical method is used in <strong>survival analysis</strong> to analyze <strong>time-to-event data</strong>, which refers to the time from entry into a study until an event of interest (eg, onset of disease, death) occurs.&nbsp; This method takes into account that any potential event (eg, event of interest, lost to follow-up, dropped out) may occur at different points in time for different study participants.&nbsp; For this reason, the KM method compares the rate at which these events occur during the entire study period rather than at the end of the study only.</p><p>The <strong>KM curve</strong> depicts the <strong>probability of survival</strong> at various <strong>time points</strong> during the study, calculated based on the proportion of subjects who are alive (or at risk for an event of interest) at different times.</p><ul><li><p>The <em>x</em>-axis denotes time from beginning to end of the study period.</p></li><li><p>The <em>y</em>-axis denotes cumulative event-free survival starting from 1.0 or 100% (ie, 100% of patients have not experienced any event) at the beginning of the study.&nbsp; As the study progresses, events occur and the proportion of subjects at risk for an event of interest decreases, causing a downward dip in the curve.</p></li></ul><p>The KM method is also used to compare survival curves between 2 groups (eg, comparing 2 different treatments, comparing a treatment group to a control [placebo] group).&nbsp; The statistical test that compares KM survival curves is the <strong>log-rank test</strong>.&nbsp; A <em>p</em>-value less than significance level alpha (usually 0.05) indicates a significant difference in survival curves between 2 groups, unlike what is seen in this study (<em>p</em> = 0.57 &gt; 0.05).</p><p>This study reported improved health survey scores in both the single-radius (SR) prosthesis group and the multiradius (MR) prosthesis group, but there were no differences between the groups (<em>p</em> &gt; 0.05).&nbsp; It also showed no difference in radiologic results (<em>p</em> &gt; 0.05) or survival results at long-term follow-up (ie, log-rank test: <em>p</em> &gt; 0.05) between the groups <strong>(Choices A and B)</strong>.</p><p>However, SR prostheses were associated with less anterior knee pain than MR prostheses (<em>p</em> &lt; 0.05).&nbsp; This means that, although both prostheses led to satisfactory outcomes, SR prostheses resulted in less anterior knee pain compared with MR prostheses.&nbsp; Therefore, the SR prosthesis should be recommended because it may result in better pain management <strong>(Choices D and E)</strong>.</p><p><strong>Educational objective:</strong><br>The Kaplan-Meier survival curve is a commonly used graphic representation of the probabilities that subjects survive in a study without an event of interest.&nbsp; The event-free survival rates of &#8805;2 study groups can be compared; they are statistically different only if the <em>p</em>-value is less than 0.05.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 18547,
            "topic": "Life expectancy and survival statistics",
            "titleId": 18547,
            "title": "Life expectancy and survival statistics",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "An MR prosthesis should be recommended because its use resulted in better overall survival estimates",
                    "choiceNumber": 1,
                    "correctTaken": 93,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "An SR prosthesis should be recommended because it has greater 10-year postoperative survival estimates",
                    "choiceNumber": 2,
                    "correctTaken": 976,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Both prostheses had satisfactory outcomes, but the SR prosthesis should be recommended because it may be better for pain management",
                    "choiceNumber": 3,
                    "correctTaken": 7835,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Either prosthesis can be recommended because there was no significant difference in outcomes between the 2 groups",
                    "choiceNumber": 4,
                    "correctTaken": 1336,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neither prosthesis should be recommended because there was no significant difference in outcomes between groups",
                    "choiceNumber": 5,
                    "correctTaken": 299,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 257,
            "othersAvgTimeSpent": 100,
            "notes": null,
            "peopleTaken": 10539,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 850,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 4095,
            "questionIndex": 4095,
            "questionText": "<p>A prospective cohort study is conducted to assess the relationship between elevated C-reactive protein level (exposure) and the development of acute coronary syndrome (disease).&nbsp; A sample of 100 adults age &gt;45 is categorized according to their C-reactive protein (CRP) levels.&nbsp; After a 5-year follow-up period, the following data were obtained:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"450\"><tbody><tr><td width=\"36%\"></td><td width=\"26%\">CRP level elevated</td><td width=\"27%\">CRP level normal</td><td width=\"12%\">Total</td></tr><tr><td width=\"36%\">Diseased</td><td width=\"26%\">10</td><td width=\"27%\">20</td><td width=\"12%\">30</td></tr><tr><td width=\"36%\">Non-diseased</td><td width=\"26%\">10</td><td width=\"27%\">60</td><td width=\"12%\">70</td></tr><tr><td width=\"36%\">Total</td><td width=\"26%\">20</td><td width=\"27%\">80</td><td width=\"12%\">100</td></tr></tbody></table></blockquote><p>What is the 5-year risk of getting acute coronary syndrome in subjects with elevated CRP levels?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Risk </strong>is the statistical likelihood of experiencing an adverse event.&nbsp; In epidemiology, risk is a measure of <strong>incidence </strong>of a disease of interest; that is, the probability of developing the disease over a certain period of time (eg, 5 years).&nbsp; To calculate the risk of a disease of interest (eg, acute coronary syndrome [ACS]) in subjects with an exposure of interest (eg, elevated C-reactive protein [CRP] level), <strong>divide</strong>:</p><p style=\"text-align: center;\">number of subjects with the <strong>exposure</strong> who develop the <strong>disease </strong><br>(eg, number of subjects with elevated CRP level who develop ACS = <strong>10</strong>)</p><p style=\"text-align: center;\"><strong>by</strong></p><p style=\"text-align: center;\"><strong>total</strong> number of subjects with the exposure (ie, <strong>exposed/at risk</strong>)&nbsp;<br>(eg, total number of subjects with elevated CRP level = <strong>20</strong>)</p><p>In this example, 10/20 = 0.5, which is interpreted as a 50% probability of developing ACS in 5 years.</p><p>Note that the data are not presented in the&nbsp;standard 2 x 2 format (with exposure status in the rows, and disease status in the columns), requiring appropriate interpretation of the values in each cell.</p><p><strong>(Choice B)</strong>&nbsp; The 5-year risk of developing ACS in all study subjects is 30/100 = 0.3 (30%).</p><p><strong>(Choice C)</strong>&nbsp; The 5-year risk of developing ACS in subjects without elevated CRP levels is 20/80 = 0.25 (25%).</p><p><strong>(Choice D)</strong>&nbsp; The prevalence of exposure (ie, elevated CRP levels) in the entire cohort (all subjects, regardless of exposure/disease status) is 20/100 = 0.2 (20%).</p><p><strong>(Choice E)</strong>&nbsp; The prevalence of exposure in nondiseased people is 10/70 =&nbsp;~0.14 (~14%).</p><p><strong>Educational objective:</strong><br>Risk is the probability of developing&nbsp;a disease over a certain period of time.&nbsp; To calculate the risk, divide the number of exposed subjects with the disease by the total number of exposed subjects (ie, all subjects at risk).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 20684,
            "topic": "Risk",
            "titleId": 20684,
            "title": "Risk",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "0.5",
                    "choiceNumber": 1,
                    "correctTaken": 193440,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "0.3",
                    "choiceNumber": 2,
                    "correctTaken": 49157,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "0.25",
                    "choiceNumber": 3,
                    "correctTaken": 25831,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "0.2",
                    "choiceNumber": 4,
                    "correctTaken": 20468,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "0.14",
                    "choiceNumber": 5,
                    "correctTaken": 7280,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 141,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 296176,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 566,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 19759,
            "questionIndex": 21248,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td id=\"vignettedescriptor\">The abstract shown on the left applies to the next <strong>2</strong> items.</td></tr></tbody></table><p>A 4-year-old girl is monitored at the hospital after undergoing cardiac surgery with cardiopulmonary bypass (CPB) to repair an acyanotic congenital heart defect.&nbsp; The procedure required aortic clamping, and CPB lasted 150 minutes.&nbsp; Maximal lactatemia during CPB was 7 mmol/L, and laboratory studies showed moderate metabolic acidosis.&nbsp; The patient subsequently develops postoperative ARF.</p><p><strong>Item 1 of 2</strong></p><p>Based on the abstract, which of the following was the most significant risk factor that contributed to this patient&#39;s developing postoperative ARF?</p>",
            "questionHeader": "",
            "explanationText": "<p>The <strong>odds ratio (OR)</strong> is a measure of association used in case-control studies to compare the <strong>odds of exposure</strong> in <strong>cases</strong> (ie, individuals with disease) relative to <strong>controls</strong> (ie, individuals without disease):</p><p style=\"text-align:center\">OR = (odds of exposure in cases) / (odds of exposure in controls)</p><p>ORs may be unadjusted or adjusted:</p><ul><li><p>An <strong>unadjusted OR</strong> estimates the association between a risk factor and an outcome but <strong>does not account</strong> (ie, control) for the effect of other variables, known as <strong>potential confounders</strong> (eg, patient demographics, clinical factors), on the outcome of interest.</p></li><li><p>An <strong>adjusted OR</strong> accounts for the effect of potential confounders, thereby minimizing confounding and providing <strong>better estimates</strong> of associations.</p></li></ul><p>A confidence interval (CI) that includes the <strong>null value</strong> (ie, <strong>OR = 1.0</strong>) is not statistically significant, and a CI that excludes the null value is statistically significant.</p><p>This study provides unadjusted (bivariate) and adjusted (multivariable) ORs for several risk factors among patients who developed ARF (cases) compared to patients who did not (controls).&nbsp; Unadjusted analysis shows that all risk factors are significantly associated with ARF (ie, CIs exclude the null value).&nbsp; However, once potential confounders (ie, age, sex, duration of CPB) are controlled in the <strong>adjusted analysis</strong>, the only <strong>statistically associated risk factors</strong> (ie, CIs exclude the null value) are:</p><ul><li><p>Moderate-to-severe <strong>hyperlactatemia</strong>: OR = 4.91; 95% CI: 1.26-19.05</p></li><li><p>Cyanotic heart disease: OR = 3.62; 95% CI: 1.11-11.63 <strong>(Choice A)</strong></p></li></ul><p>The CIs for CPB duration, metabolic acidosis, and aortic clamping in the multivariable (adjusted) analysis include the null value (OR = 1.0), so those risk factors are not statistically associated with ARF <strong>(Choices B, D, and E)</strong>.&nbsp; This implies that the variables controlled for in the adjusted analysis were distorting the true association between the risk factors and the outcome.</p><p>Based on these results, this patient&#39;s maximal lactate level of &#8805;6 mmol/L (ie, moderate-to-severe hyperlactatemia) is a risk factor for developing postoperative ARF; cyanotic heart defect is also a risk factor (ie, acyanotic heart defect is a protective factor).</p><p><strong>Educational objective:</strong><br>The odds ratio (OR) is a measure of association between an exposure and an outcome.&nbsp; Confidence intervals that contain the null value (ie, OR = 1.0) indicate that the association is not statistically significant.&nbsp; Adjusted ORs minimize confounding and provide better estimates of associations.</p>",
            "abstractId": 3893,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 8373,
            "topic": "P-value and confidence interval",
            "titleId": 8373,
            "title": "P-value and confidence interval",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 19759,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acyanotic heart defect",
                    "choiceNumber": 1,
                    "correctTaken": 200,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Duration of bypass 150 min",
                    "choiceNumber": 2,
                    "correctTaken": 4858,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maximal lactatemia 7 mmol/L",
                    "choiceNumber": 3,
                    "correctTaken": 5844,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Moderate metabolic acidosis",
                    "choiceNumber": 4,
                    "correctTaken": 256,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Need for aortic clamping",
                    "choiceNumber": 5,
                    "correctTaken": 584,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 3,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 241,
            "othersAvgTimeSpent": 116,
            "notes": null,
            "peopleTaken": 11742,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 50,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 568,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 19760,
            "questionIndex": 21249,
            "questionText": "<p><strong>Item 2 of 2</strong></p><p>Based on the abstract, which of the following is of most concern regarding this study?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Confounding bias</strong> occurs when a study does not control for <strong>extraneous variables</strong> independently related to both the risk factor and the outcome.&nbsp; When not controlled, confounders may <strong>mask the true effect</strong> that the independent variable has on the dependent variable, which may lead to <strong>false conclusions</strong> (ie, statistically significant results that are truly invalid).</p><p>In this study, a bivariate (ie, unadjusted) analysis was conducted to identify potential risk factors for ARF among children undergoing surgery with CPB.&nbsp; A <strong>multivariable (adjusted) analysis</strong> was also conducted to <strong>control</strong> for the <strong>effects of age, sex, and duration of CPB</strong> on the relationship between the risk factors (ie, aortic clamping, cardiac output syndrome, hyperlactatemia during CPB, metabolic acidosis, type of heart disease) and the outcome (ie, ARF).&nbsp; However, there may be <strong>other important risk factors</strong> for ARF after CPB that the multivariable analysis did <strong>not</strong> control for, such as preoperative creatinine level, proteinuria, albuminuria, or ACE inhibitor use.&nbsp; Therefore, limited adjustment for potential confounders may have led to residual confounding in the study.</p><p><strong>(Choice A)</strong>&nbsp; Differential mortality refers to differences in death rates between specific groups participating in follow-up studies (eg, randomized controlled trials, cohort studies).&nbsp; Because this is a case-control study, patients are not followed across time and differential mortality is not applicable.</p><p><strong>(Choice B)</strong>&nbsp; Failure to show a statistically significant association between a risk factor and an outcome is often due to insufficient power (eg, due to a small sample size) to detect an association.&nbsp; However, this study showed several statistically significant associations after adjusting for age, sex, and duration of CPB, suggesting sufficient power to detect these significant associations.&nbsp; Additional statistically significant associations may be identified with a larger sample size (ie, more power) but would not negate established associations.</p><p><strong>(Choice D)</strong>&nbsp; Misclassification of cases occurs when the outcome (eg, disease) is not assessed correctly.&nbsp; In this case-control study, cases were patients who developed ARF according to pRIFLE criteria, which standardize ARF classification based on creatinine clearance.&nbsp; Therefore, cases are clearly defined and less likely to be misclassified.</p><p><strong>Educational objective:</strong><br>Confounding bias occurs when an extraneous (ie, confounding) variable masks the relationship between an independent variable (eg, risk factor, treatment) and a dependent variable (ie, outcome, disease of interest).&nbsp; It may lead to false conclusions (ie, statistically significant results that are truly invalid).&nbsp; Failure to adjust for potential confounding factors may lead to residual confounding and a distortion of the true relationship between variables.</p>",
            "abstractId": 3893,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 6409,
            "topic": "Confounding, effect modification, bias, errors",
            "titleId": 6409,
            "title": "Confounding, effect modification, bias, errors",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 19759,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Differential mortality between cases and controls",
                    "choiceNumber": 1,
                    "correctTaken": 1852,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lack of power to detect any statistical associations",
                    "choiceNumber": 2,
                    "correctTaken": 2013,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Limited adjustment for potential confounders",
                    "choiceNumber": 3,
                    "correctTaken": 6307,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Potential misclassification of cases",
                    "choiceNumber": 4,
                    "correctTaken": 1548,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 3,
            "highlights": "853,1169,true,-1,1*1181,1351,true,-1,1*2041,2373,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 49,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 11720,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 522,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 18562,
            "questionIndex": 20033,
            "questionText": "<p>A clinical trial is conducted to assess the effectiveness of a new drug for migraine headache.&nbsp; As part of the trial design, researchers set the statistical probability values for alpha and beta at 0.05 and 0.10, respectively, and a sample of 800 adult patients with chronic migraines, selected from patients who attend headache clinics at several major academic medical centers, are randomly assigned to receive the new drug or placebo.&nbsp; Baseline scores on a standardized migraine disability assessment tool are obtained.&nbsp; Analysis of the results after 6 months of treatment shows that the new drug is associated with a clinically significant improvement in scores on the assessment tool, with a p-value of 0.04.&nbsp; Which of the following parameters would most likely have been greater if the study had been conducted using 300 subjects?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"6810\" src=\"https://www.uworld.com/media/L23287.jpg\" ></p><p>A <strong>type II error</strong> occurs when a <strong>false null hypothesis H</strong><font size=\"2\"><sub><strong>0</strong></sub></font>&nbsp;<strong>is not rejected</strong>, that is, when a study does not find a statistically significant difference although one truly exists (ie, false negative).&nbsp; The probability of a type II error (known as beta [&#946;]) is the <strong>complement</strong> of statistical <strong>power</strong> (1 &ndash; &#946;).&nbsp; Statistical power is the probability of rejecting a false H<font size=\"2\"><sub>0</sub></font>, that is, the ability to find a statistically significant difference when one truly exists (ie, true positive).</p><p>The power of a study is <strong>affected by its sample size</strong>.&nbsp; Studies with larger sample sizes have greater power to detect differences between groups when one truly exists than do studies with smaller sample sizes.&nbsp; This means that studies with <strong>smaller sample sizes</strong> have a <strong>greater probability of a type II error</strong> than do studies with larger sample sizes.&nbsp; Type I errors (ie, a true H<font size=\"2\"><sub>0</sub></font> is rejected, resulting in a false positive) and type II errors are typically inversely related to each other&mdash;as one increases, the other decreases.&nbsp; Therefore, a reduction in sample size results in a greater probability of a type II error and a <strong>lower probability of a type I error</strong> (known as alpha [&#945;]).</p><p>In this example, results show that the new drug for migraines is clinically and statistically better than placebo in a study of 800 patients.&nbsp; A study with a smaller sample size (eg, 300) would have had a lower power to detect such a difference if one truly existed <strong>(Choice E)</strong>.&nbsp; Subsequently, the study with the smaller sample size also would have had a greater probability of a type II error; it would also have resulted in a lower probability of a type I error <strong>(Choice A)</strong>.</p><p><strong>(Choices C and D)</strong>&nbsp; Sensitivity and specificity are performance parameters of a diagnostic test.&nbsp; Sensitivity is defined as the percentage of diseased individuals who are correctly identified (ie, proportion of subjects who have a positive test result among all those with disease).&nbsp; Specificity is defined as the percentage of healthy individuals who are correctly identified (ie, proportion of subjects who have a negative test result among all those without disease).&nbsp; This study is not evaluating the performance of a diagnostic test.</p><p><strong>Educational objective:</strong><br>Studies with larger sample sizes have greater power (ie, a false H<font size=\"2\"><sub>0</sub></font> is rejected) and therefore lower probability of a type II error than do studies with smaller sample sizes.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19159,
            "topic": "Power and sample size",
            "titleId": 19159,
            "title": "Power and sample size",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Likelihood of a type I error",
                    "choiceNumber": 1,
                    "correctTaken": 2319,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Likelihood of a type II error",
                    "choiceNumber": 2,
                    "correctTaken": 6689,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sensitivity of the study",
                    "choiceNumber": 3,
                    "correctTaken": 115,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Specificity of the study",
                    "choiceNumber": 4,
                    "correctTaken": 100,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Statistical power",
                    "choiceNumber": 5,
                    "correctTaken": 1359,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "227,331,true,-1,1*852,1183,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 226,
            "othersAvgTimeSpent": 62,
            "notes": null,
            "peopleTaken": 10582,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 701,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 4079,
            "questionIndex": 4079,
            "questionText": "<p>A study was conducted to assess the association between hormone replacement therapy (HRT) in post-menopausal women and the level of serum C-reactive protein (CRP), categorized as &#x22;high&#x22; or &#x22;normal&#x22; based on predefined values.&nbsp; The data from the study are presented below:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"325\"><tbody><tr><td width=\"25%\"></td><td width=\"26%\">CRP high</td><td width=\"34%\">CRP normal</td><td width=\"15%\">Total</td></tr><tr><td width=\"25%\">HRT</td><td width=\"26%\">32</td><td width=\"34%\">41</td><td width=\"15%\">73</td></tr><tr><td width=\"25%\">No HRT</td><td width=\"26%\">28</td><td width=\"34%\">49</td><td width=\"15%\">77</td></tr><tr><td width=\"25%\">Total</td><td width=\"26%\">60</td><td width=\"34%\">90</td><td width=\"15%\">150</td></tr></tbody></table></blockquote><p>Which of the following is the best statistical method to assess the association between HRT and CRP levels?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35860\"><table class=\"table-default-style table-footer-only-style\" style=\"width:100.0%\"><tbody><tr><td style=\"border: 0px !important;\"></td><td style=\"border: 0px !important;\"></td><td colspan=\"2\" style=\"width:50.0%;\"><p align=\"center\"><strong>Dependent variable</strong></p></td></tr><tr><td style=\"border: 0px !important;\"></td><td style=\"border: 0px !important;\"></td><td style=\"width:25.0%;\"><p align=\"center\"><em>Qualitative (categorical)</em></p></td><td style=\"width:25.0%;\"><p align=\"center\"><em>Quantitative </em></p></td></tr><tr><td rowspan=\"2\" style=\"width:25.0%;\"><p align=\"center\"><strong>Independent variable</strong></p></td><td style=\"width:25.0%;\"><p align=\"center\"><em>Qualitative (categorical)</em></p></td><td style=\"width:25.0%;\"><p align=\"center\">Chi-square, logistic regression*</p></td><td style=\"width:25.0%;\"><p align=\"center\"><em>t</em> test, ANOVA, linear regression</p></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><em>Quantitative</em></p></td><td style=\"width:25.0%;\"><p align=\"center\">Logistic regression*</p></td><td style=\"width:25.0%;\"><p align=\"center\">Correlation, linear regression</p></td></tr><tr><td colspan=\"4\" style=\"width:100.0%;\"><p>*Dependent variable must be dichotomous.</p><p><strong>ANOVA</strong> = &nbsp;analysis of variance.</p></td></tr></tbody></table></div><p>Variables are broadly classified as qualitative (ie, categorical) or quantitative (ie, continuous) based on the scale of measurement.&nbsp; <strong>Qualitative variables</strong> (eg, type of treatment, blood type) represent categories or groups, whereas <strong>quantitative variables</strong> (eg, temperature, glucose level) represent numerical values.&nbsp; The scale of measurement of the dependent (eg, outcome) and independent (eg, exposure, risk factor) variables in a study determines the correct statistical test for any given situation.</p><p>The <strong>chi-square test</strong> is used to compare the <strong>proportions </strong>of a categorized outcome with a qualitative (<strong>categorical</strong>) <strong>independent </strong>variable and a qualitative (<strong>categorical</strong>) <strong>dependent </strong>variable.&nbsp; In this case, the outcome (CRP level) is categorized as either &#x22;high&#x22; and &#x22;normal,&#x22; and then presented with the categorized exposure (&#x22;HRT&#x22; or &#x22;no HRT&#x22;) in a 2 &times; 2 table.&nbsp; In one of the commonly used chi-square tests, the observed values in each of the cells are compared to expected (under the hypothesis of no association) values.&nbsp; If the difference between the observed and expected values is large, an association between the exposure and the outcome is assumed to be present.</p><p><strong>(Choice A)</strong>&nbsp; Correlation analysis measures the strength and direction of a linear relationship between 2 quantitative variables.&nbsp; In the given 2 &times; 2 table, the variables are categorized (ie, qualitative rather than quantitative).<p><strong>(Choices B and D)</strong>&nbsp; The two-sample z-test and two-sample t-test are used to compare 2 means, not proportions.&nbsp; Analysis of variance (ANOVA) is used to compare the means of &#8805;2 variables.</p><p><strong>(Choice E)</strong>&nbsp; Meta-analysis is an epidemiologic method of pooling the data from several studies to do an analysis having a relatively big statistical power.</p><p><strong>Educational objective:</strong><br>The chi-square test is used to compare proportions.&nbsp; A 2 &times; 2 table may be used to compare the observed values with the expected values.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 15780,
            "topic": "Statistical tests",
            "titleId": 15780,
            "title": "Statistical tests",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Correlation analysis",
                    "choiceNumber": 1,
                    "correctTaken": 15362,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Two-sample t-test",
                    "choiceNumber": 2,
                    "correctTaken": 96873,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chi-square test",
                    "choiceNumber": 3,
                    "correctTaken": 163537,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "ANOVA",
                    "choiceNumber": 4,
                    "correctTaken": 15025,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Meta-analysis",
                    "choiceNumber": 5,
                    "correctTaken": 5745,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1371,1513,true,-1,1*2041,2082,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 45,
            "othersAvgTimeSpent": 36,
            "notes": null,
            "peopleTaken": 296542,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 931,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 19020,
            "questionIndex": 20503,
            "questionText": "<p>A group of researchers is investigating whether the availability of green spaces (eg, grass, forests, parks) within people&#39;s living environments is associated with depression-associated mortality.&nbsp; Data of officially confirmed deaths related to depression during the past 10 years are collected in a random sample of counties across the United States.&nbsp; A geographic information system is used to calculate the percentage of green spaces in each county.&nbsp; During data analysis, the percentage of green spaces is categorized as low (&#8804;25%), moderate (&gt;25% to &#8804;85%), or high (&gt;85%).&nbsp; An excerpt of study results is shown below:</p><div id=\"div_T65696\"><table class=\"table-default-style table-footer-only-style\"><tbody><tr><td><p style=\"text-align: center;\"><strong>Green spaces</strong></p></td><td><p style=\"text-align: center;\"><strong>Relative risk of<br>depression-associated mortality*</strong></p></td><td><p style=\"text-align: center;\"><strong>95% confidence interval</strong></p></td></tr><tr><td><p>Moderate</p></td><td><p align=\"center\">0.831</p></td><td><p align=\"center\">0.762-0.907</p></td></tr><tr><td><p>High</p></td><td><p align=\"center\">0.760</p></td><td><p align=\"center\">0.681-0.849</p></td></tr><tr><td colspan=\"3\"><p>*Reference group = Low.</p></td></tr></tbody></table></div><p>Which of the following is the best statement concerning the results of the study?</p>",
            "questionHeader": "",
            "explanationText": "<p>In this study, researchers collected <strong>county-level data</strong> on depression-associated mortality (eg, county-level proportion of death certificates where depression was listed as a contributing factor) and calculated the percentage of green spaces in each county to determine whether the presence of green spaces is associated with depression-associated mortality.&nbsp; They did not collect any individual-level data.&nbsp; This is consistent with an <strong>ecological study</strong> design, in which the rates of an outcome (eg, rate of depression-associated mortality) and exposures (eg, high percentage of green spaces) are measured at the <strong>population or community</strong> (eg, county) <strong>level</strong>, and their association is examined.</p><p>The results suggest that compared to counties with a low percentage of green space (reference group), counties with a moderate or high percentage of green space have a lower risk of depression-associated mortality because the corresponding relative risks (RRs) of 0.831 and 0.760 are both &lt;1.&nbsp; Both 95% <strong>confidence intervals for the RR exclude the null value</strong> of 1; this indicates that the results are statistically significant.&nbsp; Therefore, the percentage of green spaces in living environments is <strong>significantly associated</strong> with depression-associated mortality.</p><p>Although ecological studies are commonly used to generate hypotheses and may establish associations between risk factors and outcomes, results from this type of study cannot establish causality <strong>(Choices A and B)</strong>.&nbsp; They are also not valid for making inferences regarding subjects (eg, <strong>individuals</strong>) within these populations because results offer information at the population (eg, county) level rather than at the subject level <strong>(Choices C and D)</strong>.&nbsp; This phenomenon is known as the <strong>ecological fallacy</strong>.&nbsp; The fallacy assumes that individuals of a population all have the average characteristics of the population as whole, but any association observed between variables at the population level does not necessarily mean that the same association exists for any individual selected from the population (eg, a subject living in an environment with a high percentage of green spaces may not have a lower risk of depression-associated mortality).</p><p><strong>Educational objective:</strong><br>In ecological studies, the unit of observation is the population.&nbsp; Disease rates and exposures are measured in each of a series of populations, and their association is determined.&nbsp; Therefore, results about associations at the population level may not translate to the subject level.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19502,
            "topic": "Study designs",
            "titleId": 19502,
            "title": "Study designs",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "A high percentage of green spaces within living environments causes a significant decrease in depression-associated mortality",
                    "choiceNumber": 1,
                    "correctTaken": 599,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "A high percentage of green spaces within living environments can prevent depression-associated mortality",
                    "choiceNumber": 2,
                    "correctTaken": 196,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "An individual living in an environment with a high percentage of green spaces has a significantly lower risk of depression-associated mortality than an individual living in an environment with a low percentage of green spaces",
                    "choiceNumber": 3,
                    "correctTaken": 4368,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "An individual living in an environment with a high percentage of green spaces has the same risk of depression-associated mortality as an individual living in an environment with a low percentage of green spaces",
                    "choiceNumber": 4,
                    "correctTaken": 1030,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is a statistically significant association between the percentage of green spaces in living environments and depression-associated mortality",
                    "choiceNumber": 5,
                    "correctTaken": 4308,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1279,1472,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 306,
            "othersAvgTimeSpent": 105,
            "notes": null,
            "peopleTaken": 10501,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 41,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 668,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 18949,
            "questionIndex": 20430,
            "questionText": "<p>A medical student conducting a literature search about breastfeeding and HIV is reviewing a randomized controlled trial in which women who were HIV seropositive were randomly assigned to either breastfeed or formula feed their infants.&nbsp; After delivery, mother-infant pairs were followed monthly during the first year and quarterly during the second year until the mother&#39;s death, or until 2 years after delivery.&nbsp; The study reported that the cumulative mortality rate at 24 months after delivery was 11.2% in the breastfeeding group and 3.5% in the formula-feeding group (<em>p</em> = 0.02).&nbsp; Based on these results, what is the approximate percentage of maternal deaths in the breastfeeding group that can be attributed to breastfeeding?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Attributable risk percentage (ARP)</strong> describes the percentage of disease in an exposed group that can be attributed to the exposure.&nbsp; It is sometimes described as the percentage of disease in an exposed group that could be prevented by eliminating the risk factor.</p><p>ARP is calculated as the <strong>difference in risk of disease</strong> between an exposed group and a nonexposed group <strong>divided</strong> by the <strong>risk of disease</strong> in the <strong>exposed group</strong>:</p><div style=\"margin-left: 3em;\"><p>ARP = [(Risk<font size=\"2\"><sub>exposed</sub></font> &#8722; Risk<font size=\"2\"><sub>nonexposed</sub></font>) / Risk<font size=\"2\"><sub>exposed</sub></font>] &times; 100</p></div><p>According to the article, the risk of disease (ie, death) in the exposed (ie, breastfeeding) group was 11.2% (or 0.112) <strong>(Choice C)</strong>.&nbsp; In the nonexposed (ie, formula-feeding) group, the risk was 3.5% (or 0.035) <strong>(Choice B)</strong>.&nbsp; Therefore:</p><div style=\"margin-left: 3em;\"><p>ARP = [(Risk<font size=\"2\"><sub>exposed</sub></font> &#8722; Risk<font size=\"2\"><sub>nonexposed</sub></font>) / Risk<font size=\"2\"><sub>exposed</sub></font>] &times; 100 = [(0.112 &#8722; 0.035) / 0.112)] &times; 100 = 68.75%</p></div><p>Therefore, the approximate percentage of maternal deaths in the breastfeeding group that can be attributed to breastfeeding is 68.8%.</p><p>Alternately, ARP may be calculated using relative risk (RR):</p><div style=\"margin-left: 3em;\"><p>ARP = [(RR &ndash; 1) / RR] &times; 100</p></div><p>For this example, RR is the ratio of risk of disease (ie, death) in the exposed (ie, breastfeeding) group to the risk of disease (ie, death) in the nonexposed (ie, formula-feeding) group.&nbsp; It is calculated as:</p><div style=\"margin-left: 3em;\"><p>RR = (Risk<font size=\"2\"><sub>exposed</sub></font> / Risk<font size=\"2\"><sub>nonexposed</sub></font>) = (0.112 / 0.035) = 3.2 <strong>(Choice A)</strong></p></div><p>Therefore:</p><div style=\"margin-left: 3em;\"><p>ARP = [(RR &#8722; 1) / RR] &times; 100 = [(3.2 &#8722; 1) / 3.2] &times; 100 = 68.75% ~ 68.8%</p></div><p>For mothers with HIV, formula feeding is recommended in resource-rich settings but not in resource-poor settings where it is associated with increased infant mortality rates due to waterborne pathogens (diarrhea), pneumonia, and other infections.</p><p><strong>(Choices B and D)</strong>&nbsp; Absolute risk increase (ARI) is the difference in the risk of a negative outcome (eg, death) between an exposed (eg, breastfeeding) group and a nonexposed (eg, formula-feeding) group.&nbsp; It is calculated as:</p><div style=\"margin-left: 3em;\"><p>ARI = (Risk<font size=\"2\"><sub>exposed</sub></font> &#8722; Risk<font size=\"2\"><sub>nonexposed</sub></font>) = (0.112 &#8722; 0.035) = 0.077 (or 7.7%)</p></div><p>Number needed to harm (NNH) is the number of people who must be exposed to a treatment to cause harm to 1 person who otherwise would not have been harmed.&nbsp; It is calculated as:</p><div style=\"margin-left: 3em;\"><p>NNH = 1 / ARI = 1 / 0.077 = 12.99 ~ 13 (not a percentage)</p></div><p>ARP is different from attributable risk, which is another name for the difference in absolute risks (eg, Risk<font size=\"2\"><sub>exposed</sub></font> &#8722; Risk<font size=\"2\"><sub>nonexposed</sub></font>).</p><p><strong>Educational objective:</strong><br>Attributable risk percentage (ARP) describes the percentage of disease in an exposed group that can be attributed to the exposure.&nbsp; It is calculated as the difference in risk of disease between the exposed and nonexposed groups divided by the risk of disease in the exposed group: ARP = [(Risk<font size=\"2\"><sub>exposed</sub></font> &#8722; Risk<font size=\"2\"><sub>nonexposed</sub></font>) / Risk<font size=\"2\"><sub>exposed</sub></font>] &times; 100</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 29979,
            "topic": "Measures of association",
            "titleId": 29979,
            "title": "Measures of association",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "3.2",
                    "choiceNumber": 1,
                    "correctTaken": 773,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "3.5",
                    "choiceNumber": 2,
                    "correctTaken": 280,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "11.2",
                    "choiceNumber": 3,
                    "correctTaken": 1204,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "13.0",
                    "choiceNumber": 4,
                    "correctTaken": 510,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "68.8",
                    "choiceNumber": 5,
                    "correctTaken": 2766,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1430,1676,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 261,
            "othersAvgTimeSpent": 116,
            "notes": null,
            "peopleTaken": 5533,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 50,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1661,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 3941,
            "questionIndex": 3941,
            "questionText": "<p>A large clinical trial is performed to evaluate the treatment response to statins in statin-naive patients admitted for anginal chest pain.&nbsp; Patients are randomly assigned to moderate- or high-dose statin therapy upon discharge.&nbsp; At 3 months, the adverse cardiovascular event rate in the high-dose group compared to the moderate-dose group was 0.98 with a <em>p</em> value of 0.80.&nbsp; At 1 year, the relative risk ratio was 0.67 with a <em>p</em> value of 0.01.&nbsp; Treatment and follow-up compliance was high in both groups throughout the study interval.&nbsp; The difference between the 2 risk estimates is best explained by which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<p>Latency is an important natural phenomenon of disease epidemiology.&nbsp; Most infectious diseases have relatively short latency periods (ie, the time elapsed from initial exposure to clinically apparent disease).&nbsp; In contrast, some disease processes (eg, cancer, heart disease) have a long latency period before clinical manifestations develop.</p><p>The concept of a latency period can also be extended to risk factors and risk reducers.&nbsp; Sometimes, a significant amount of time must pass before exposure to a risk modifier has a clinically evident effect on the disease process.&nbsp; In addition, exposure to a risk modifier may need to occur continuously over a certain period before the disease outcome is affected.&nbsp; In this case, at least 1 year of high-dose statin therapy was required to show a significant protective advantage over moderate-dose therapy.</p><p><strong>(Choice A)</strong>&nbsp; Confounding bias occurs when a perceived exposure-disease relationship is actually caused by an extraneous factor that correlates with both the exposure and the disease.&nbsp; There is no information suggesting that confounding occurred in this study.</p><p><strong>(Choice C)</strong>&nbsp; Observer bias occurs when an observer misclassifies data due to individual differences in interpretation or preconceived expectations regarding the study.&nbsp; It can be reduced by performing a double-blind study with multiple observers to encode and verify recorded data.</p><p><strong>(Choice D)</strong>&nbsp; Selection bias can occur with inappropriate (ie, nonrandom) assignment methods or through selective attrition of the study participants.&nbsp; It results in a study population that does not accurately represent the actual population, leading to erroneous conclusions regarding the exposure-disease relationship.</p><p><strong>(Choice E)</strong>&nbsp; Selective survival bias occurs in case-control studies when cases are selected from the entire disease population instead of just those that are newly diagnosed.&nbsp; For instance, a study on cancer survival that is not limited to newly diagnosed patients will contain a higher proportion of relatively benign malignancies as these patients generally live longer.</p><p><strong>Educational objective:</strong><br>The concept of a latency period can be applied to both disease pathogenesis and exposure to risk modifiers.&nbsp; Exposure to risk factors and the initial steps in disease pathogenesis sometimes occur years before clinical manifestations are evident.&nbsp; In addition, exposure to risk modifiers may need to be continuous over a certain period before influencing the outcome.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24175,
            "topic": "Bias",
            "titleId": 24175,
            "title": "Bias",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Confounding bias",
                    "choiceNumber": 1,
                    "correctTaken": 6172,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Latency period",
                    "choiceNumber": 2,
                    "correctTaken": 73326,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observer bias",
                    "choiceNumber": 3,
                    "correctTaken": 2794,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Selection bias",
                    "choiceNumber": 4,
                    "correctTaken": 4763,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Selective survival bias",
                    "choiceNumber": 5,
                    "correctTaken": 17807,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1305,1418,true,-1,1*1750,2108,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 100,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 104862,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 975,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 20162,
            "questionIndex": 21656,
            "questionText": "<p>A new potential blood test for diagnosing Alzheimer disease is evaluated in Populations A and B.&nbsp; The negative predictive value is estimated at 98% in Population A and at 85% in Population B.&nbsp; Which of the following is the most likely explanation for these findings?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"40170\" src=\"https://www.uworld.com/media/L66255.png\"  ></p><p>The <strong>negative predictive value (NPV)</strong>, the probability that an individual truly does not have a disease given a negative test result, is equal to the number of individuals without disease and who test negative (ie, true negatives [TN]) divided by all those with a negative test result (ie, TN + false negative [FN]):</p><p style=\"text-align:center\">NPV = TN / (TN + FN)</p><p>Similarly, the positive predictive value (PPV), the probability that an individual truly has the disease (ie, true positive [TP]) given a positive test result (including TP or false positive [FP] results), is given by:</p><p style=\"text-align:center\">PPV = TP / (TP + FP)</p><p><a href=\"1305\">Predictive values</a> depend on disease <strong>prevalence</strong> in a population of interest.&nbsp; Specifically, disease prevalence affects NPV by changing TN and FN.</p><ul><li><p>Populations with exceptionally <strong>low disease prevalence</strong> (eg, prevalence close to 0%) have almost all TN (ie, more TN) with almost no TP (ie, fewer TP), and most positive tests would be FP (ie, more FP) with almost no FN (ie, fewer FN).&nbsp; This explains why <strong>NPV increases</strong> (more TN, fewer FN) and <strong>PPV decreases</strong> (fewer TP, more FP) with decreasing prevalence.</p></li><li><p>Populations with exceptionally <strong>high disease prevalence</strong> (eg, prevalence close to 100%) have almost all TP (ie, more TP) with almost no TN (ie, fewer TN), and most negative tests would be FN (ie, more FN) with almost no FP (ie, fewer FP).&nbsp; This explains why <strong>NPV decreases</strong> (fewer TN, more FN) and <strong>PPV increases</strong> (more TP, fewer FP) with increasing prevalence.</p></li></ul><p>In this case, the test has a <strong>higher NPV</strong> (98%) in Population A than in Population B (NPV = 85%).&nbsp; This implies that <strong>Population A</strong> has a <strong>lower disease prevalence</strong> than Population B <strong>(Choice B)</strong>.&nbsp; Therefore, the proportion of patients without Alzheimer disease is greater in population A than in population B.</p><p><strong>(Choice A)</strong>&nbsp; The accuracy of a diagnostic test is the probability that an individual is correctly classified by the test: accuracy = (TP + TN) / (TP + TN + FP + FN).&nbsp; Because no information is given on these specific values, no conclusions regarding accuracy can be made.</p><p><strong>(Choices D and E)</strong>&nbsp; Sensitivity and specificity are intrinsic test parameters that are not affected by disease prevalence.&nbsp; The same test was used in Populations A and B, so there is no change in sensitivity and specificity.</p><p><strong>Educational objective:</strong><br>Predictive values depend on disease prevalence.&nbsp; As disease prevalence increases, the positive predictive value increases and the negative predictive value decreases.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 10211,
            "topic": "Sensitivity, specificity, NPV, PPV",
            "titleId": 10211,
            "title": "Sensitivity, specificity, NPV, PPV",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "The accuracy of the test is greater in Population A than in Population B",
                    "choiceNumber": 1,
                    "correctTaken": 648,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The prevalence of Alzheimer disease is greater in Population A than in Population B",
                    "choiceNumber": 2,
                    "correctTaken": 1376,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The proportion of patients without Alzheimer disease is greater in population A than in population B",
                    "choiceNumber": 3,
                    "correctTaken": 6473,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The sensitivity of the test is lower in Population A than in Population B",
                    "choiceNumber": 4,
                    "correctTaken": 390,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The specificity of the test is greater in Population A than in Population B",
                    "choiceNumber": 5,
                    "correctTaken": 1697,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2057,2158,true,-1,1*1882,1929,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 144,
            "othersAvgTimeSpent": 67,
            "notes": null,
            "peopleTaken": 10584,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1168,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 19401,
            "questionIndex": 20886,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td id=\"vignettedescriptor\">The abstract shown on the left applies to the next <strong>2</strong> items.</td></tr></tbody></table><p>A 28-year-old primigravida woman comes to the office due to inability to conceive despite appropriately timed, unprotected intercourse for the past 6 months.&nbsp; The patient has had no abnormal Pap tests.&nbsp; She and her husband have no chronic medical conditions or previous surgeries.&nbsp; The patient does not use alcohol or illicit drugs.&nbsp; She drinks &gt;1 cup of coffee per day and is a moderate smoker.&nbsp; Blood pressure is 110/70 mm Hg, and pulse is 68/min.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination reveals a soft, nontender abdomen with no masses.&nbsp; The patient&#39;s N-acetyltransferase 2 (NAT2) acetylator status is unknown.</p><p><strong>Item 1 of 2</strong></p><p>Which of the following conclusions can be drawn from the results of the study?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"44657\" src=\"https://www.uworld.com/media/L70115.png\" ></p><p>This study evaluated how caffeine, alcohol, and smoking associate with fecundability in women age 20-41 at risk for pregnancy.&nbsp; The initial results (ie, unstratified analysis) show that fecundability is significantly associated with alcohol (ie, confidence interval [CI] for the odds ratio [OR] excluded the null value [OR = 1]) but not with caffeine or current smoking (ie, CIs included the null value).&nbsp; A subsequent stratified analysis was conducted based on participants&#39; N-acetyltransferase 2 (NAT2) acetylator phenotypes to determine whether NAT2 status (ie, slow or rapid acetylation) helps explain these associations.&nbsp; The <strong>stratified analysis</strong> shows that some of these <strong>associations</strong> were <strong>inconsistent</strong> across <strong>NAT2 status</strong> (ie, slow or rapid acetylators).</p><ul><li><p>Among <strong>slow acetylators</strong>, fecundability was <strong>significantly associated</strong> with <strong>alcohol</strong> and <strong>smoking</strong> because the CIs excluded the null value of OR = 1 (95% CI: 0.07 to 0.56 for NAT2/alcohol; 95% CI: 0.23 to 0.48 for NAT2/smoking).&nbsp; However, fecundability was not significantly associated with caffeine because the CI included the null value of OR = 1 (95% CI: 0.67 to 1.62 for NAT2/caffeine).</p></li><li><p>Among <strong>rapid acetylators</strong>, fecundability was <strong>not significantly associated</strong> with caffeine, alcohol, or smoking because all CIs included the null value of OR = 1 (95% CI: 0.50 to 1.85 for NAT2/caffeine; 95% CI: 0.61 to 2.22 for NAT2/alcohol; 95% CI: 0.93 to 2.94 for NAT2/smoking) <strong>(Choice A)</strong>.</p></li></ul><p>Therefore, the effect of smoking and alcohol on fecundability is modified by NAT2 status&mdash;NAT2 status is an <strong>effect modifier</strong>.&nbsp; Effect modification <strong>(interaction)</strong> occurs when an extraneous variable (effect modifier) <strong>changes the effect</strong> an exposure (eg, treatment) has on an outcome in <strong>certain groups</strong> of individuals but not others.&nbsp; A <strong>stratified analysis</strong> based on the modifier can help detect effect modification because it typically shows <strong>different effects in each stratum</strong>.</p><p><strong>(Choices B and D)</strong>&nbsp; Based on the abstract, fecundability is not significantly associated with caffeine or NAT2 status because the corresponding CIs included the null value (95% CI: 0.58 to 1.38 for the association between fecundability and caffeine; 95% CI: 0.89 to 2.35 for the association between fecundability and NAT2 status).</p><p><strong>Educational objective:</strong><br>Effect modification occurs when the magnitude or direction of the effect of the independent variable on the dependent variable (outcome) varies depending on the level of a third variable (effect modifier).&nbsp; Separate (stratified) analyses should be conducted for each level of the effect modifier.</p>",
            "abstractId": 3769,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 6409,
            "topic": "Confounding, effect modification, bias, errors",
            "titleId": 6409,
            "title": "Confounding, effect modification, bias, errors",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 19401,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alcohol has a significant effect on fecundability among rapid acetylators",
                    "choiceNumber": 1,
                    "correctTaken": 1788,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fecundability is significantly associated with NAT2 status",
                    "choiceNumber": 2,
                    "correctTaken": 430,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The effect of smoking and alcohol on fecundability is modified by NAT2 status",
                    "choiceNumber": 3,
                    "correctTaken": 8977,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is a significant association between caffeine and fecundability regardless of NAT2 status",
                    "choiceNumber": 4,
                    "correctTaken": 552,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 3,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 192,
            "othersAvgTimeSpent": 149,
            "notes": null,
            "peopleTaken": 11747,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 924,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 19402,
            "questionIndex": 20887,
            "questionText": "<p><strong>Item 2 of 2</strong></p><p>Assuming the patient has the slow acetylator phenotype, which of the following statements is most accurate?</p>",
            "questionHeader": "",
            "explanationText": "<p>Based on the stratified analysis in the abstract, the estimated odds ratio (OR) and 95% confidence interval (CI) for the association between fecundability and caffeine, alcohol, and smoking among women with the <strong>slow</strong> acetylator phenotype were as follows:</p><ul><li><p>Caffeine (&#8805;300 mg/day vs &lt;300 mg/day): OR = 0.81; 95% CI: 0.67 to 1.62</p></li><li><p><strong>Alcohol</strong> (&#8805;1 drinks/day vs &lt;1 drink/day): OR = 0.20; 95% CI: 0.07 to 0.56</p></li><li><p><strong>Smoking</strong> (current smoker vs nonsmoker): OR = 0.34; 95% CI: 0.23 to 0.48</p></li></ul><p>The CIs for alcohol and smoking <strong>excluded the null value</strong> (OR = 1), suggesting that fecundability is <strong>significantly associated</strong> with alcohol and smoking.&nbsp; In contrast, the CI for caffeine included the null value, suggesting that fecundability is not associated with caffeine <strong>(Choice C)</strong>.&nbsp; Because the corresponding <strong>ORs</strong> are <strong>&lt;1</strong>, alcohol and smoking are associated with a significant <strong>decrease</strong> in the odds of fecundability <strong>(Choices A and D)</strong>.&nbsp; Therefore, women who have the slow acetylator phenotype have significantly lower odds of fecundability if they use alcohol or smoke.</p><p><strong>(Choice B)</strong>&nbsp; Based on the abstract, N-acetyltransferase 2 (NAT2) acetylator status alone is not significantly associated with fecundability (OR = 1.44; 95% CI: 0.89 to 2.35).&nbsp; This indicates that NAT2 acetylator status is not independently associated with fecundability.&nbsp; Therefore, having the slow acetylator phenotype does not affect fecundability.</p><p><strong>Educational objective:</strong><br>An odds ratio (OR) &lt;1 indicates that the exposure (eg, caffeine) is associated with a decrease in odds of an outcome (eg, fecundability).&nbsp; A confidence interval that excludes the null value (ie, OR = 1) is statistically significant.</p>",
            "abstractId": 3769,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 29979,
            "topic": "Measures of association",
            "titleId": 29979,
            "title": "Measures of association",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 19401,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Caffeine, alcohol, and smoking significantly reduce the odds of fecundability in women with the slow acetylator phenotype",
                    "choiceNumber": 1,
                    "correctTaken": 384,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Having the slow acetylator phenotype significantly decreases the odds of fecundability",
                    "choiceNumber": 2,
                    "correctTaken": 508,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The only factor that significantly reduces the odds of fecundability among women with the slow acetylator phenotype is caffeine",
                    "choiceNumber": 3,
                    "correctTaken": 299,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is no significant association between caffeine, alcohol, or smoking and fecundability among women with the slow acetylator phenotype",
                    "choiceNumber": 4,
                    "correctTaken": 1012,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Women with the slow acetylator phenotype have significantly lower odds of fecundability if they use alcohol or smoke",
                    "choiceNumber": 5,
                    "correctTaken": 9506,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 3,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 72,
            "othersAvgTimeSpent": 49,
            "notes": null,
            "peopleTaken": 11709,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 81,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 219,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 18841,
            "questionIndex": 20318,
            "questionText": "<p>A study is conducted to determine whether administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in the first trimester improves pregnancy outcomes among women with a history of unexplained recurrent pregnancy loss.&nbsp; One hundred fifty women with a history of unexplained recurrent pregnancy loss are randomly assigned to receive either rhG-CSF or placebo.&nbsp; Daily subcutaneous injections of rhG-CSF (130 mcg) or identical-appearing placebo are administered as early as 3-5 weeks gestation for a maximum of 9 weeks.&nbsp; The primary outcome is clinical pregnancy at 20 weeks gestation, as demonstrated by ultrasound scan.&nbsp; Which of the following is the most appropriate statistical measure to determine whether rhG-CSF influences the primary outcome in this study?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"6804\" src=\"https://www.uworld.com/media/L13767.jpg\" ></p><p>This study design is a <strong>randomized controlled trial (RCT)</strong> in which participants are <strong>initially randomly assigned</strong> to receive either a treatment (ie, recombinant human granulocyte colony-stimulating factor [rhG-CSF]) or a placebo according to the independent variable (ie, treatment, exposure).&nbsp; Once participants are randomized into groups, the occurrence (ie, incidence, rate) of the dependent variable (ie, clinical pregnancy) within a specific period is determined in each group.&nbsp; Finally, the <strong>rate of the outcome</strong> is compared between the treatment group and the placebo group to estimate the <strong>association</strong> between the treatment and the outcome.&nbsp; A common measure of association in RCTs is <strong>relative risk (RR)</strong>, calculated as follows:</p><div><p style=\"text-align:center; min-width:650px;\"><strong>RR</strong> = (rate of outcome in treatment group) / (rate of outcome in placebo group)</p></div><p>The RR may compare the rate (ie, risk) of an outcome between 2 different treatment groups, one of which serves as a control group, or between a treatment group and a placebo group.</p><p>The rationale for studying rhG-CSF in recurrent pregnancy loss is that it may modulate the immune response to the fetus.</p><p><strong>(Choices A and B)</strong>&nbsp; Hazard ratio and median survival are measures of association for time-to-event (survival) outcomes commonly used in cohort studies and experimental designs.&nbsp; They compare total and median survival times, respectively, in &#8805;2 groups of patients (eg, those receiving a new treatment and those receiving a placebo).&nbsp; However, this study does not have a time-to-event (survival) outcome.</p><p><strong>(Choice C)</strong>&nbsp; Odds ratio is calculated in case-control studies, in which 2 groups of individuals are initially identified as cases or controls according to an outcome (eg, disease of interest).&nbsp; Finally, the frequency of exposure to the risk factors is compared between groups to estimate the association between the risk factors and the outcomes.</p><p><strong>(Choice D)</strong>&nbsp; Prevalence ratio is a ratio of 2 prevalence estimates commonly used in cross-sectional studies to compare the prevalence of disease among exposed and nonexposed groups of people.&nbsp; In RCTs, the goal is to estimate and compare the incidence of an outcome in groups of individuals randomly assigned to one of several treatments or placebo.&nbsp; Therefore, estimating the prevalence of disease in RCTs is not possible.</p><p><strong>Educational objective:</strong><br>A randomized controlled trial is used to estimate and compare the incidence of an outcome in groups of individuals randomly assigned to one of several treatments or placebo.&nbsp; A common measure of association is relative risk.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19502,
            "topic": "Study designs",
            "titleId": 19502,
            "title": "Study designs",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Hazard ratio",
                    "choiceNumber": 1,
                    "correctTaken": 1489,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Median survival",
                    "choiceNumber": 2,
                    "correctTaken": 929,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Odds ratio",
                    "choiceNumber": 3,
                    "correctTaken": 2970,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prevalence ratio",
                    "choiceNumber": 4,
                    "correctTaken": 696,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Relative risk",
                    "choiceNumber": 5,
                    "correctTaken": 4571,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "841,1020,true,-1,1*1161,1544,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 271,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 10655,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 43,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 662,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 11523,
            "questionIndex": 12684,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\"><tbody><tr><td bgcolor=\"#c0c0c0\">The following vignette applies to the next <strong>2</strong> items.</td></tr></tbody></table><p>Graduate students at a school of public health are analyzing the results of a study they conducted at a community health fair.&nbsp; The students approached fairgoers at random and asked them if they would be willing to answer questions about health-related topics; 90% of those approached agreed to participate.&nbsp; Using a prewritten questionnaire, the students asked the participants standardized questions and recorded the answers.&nbsp; In addition to obtaining basic demographic data, students inquired about the amount of carbonated beverages consumed in each household and also asked participants to estimate prevalence of obesity in their household.&nbsp; By comparing the demographic data they gathered to those from a recent official demographic census, the students determined that the fair was well attended by a representative sample of the community.&nbsp; Their results suggest that the self-reported prevalence of obesity among household members is approximately 25% and that there is no association between household consumption of carbonated beverages and reported prevalence of obesity.</p><p><strong>Item 1 of 2</strong></p><p>Which of the following best describes the study design?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t31863\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Types of studies in the health sciences</strong></p></td></tr><tr><td colspan=\"2\"><p align=\"center\"><strong>Experimental</strong></p></td></tr><tr><td><p align=\"center\"><strong>Randomized controlled trial</strong></p></td><td><ul><li>Random allocation into treatment &amp; placebo groups</li><li>Can determine efficacy of the intervention</li></ul></td></tr><tr><td><p align=\"center\"><strong>Nonrandomized design</strong></p></td><td><ul><li>Nonrandom allocation into treatment &amp; placebo groups</li><li>Can determine efficacy of the intervention</li></ul></td></tr><tr><td colspan=\"2\"><p align=\"center\"><strong>Observational</strong></p></td></tr><tr><td><p align=\"center\"><strong>Cohort</strong></p></td><td><ul><li>Data gathered from the same individuals over time (longitudinal)</li><li>Can assess risk factors or outcomes</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cross-sectional</strong></p></td><td><ul><li>Data gathered at one point in time</li><li>Can determine prevalence of an outcome in a population</li></ul></td></tr><tr><td><p align=\"center\"><strong>Case-control</strong></p></td><td><ul><li>Data gathered from individuals with the condition of interest (cases) &amp; compared to individuals without the condition (controls)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Case</strong></p></td><td><ul><li>Detailed information gathered about one individual (or a small group of individuals)</li></ul></td></tr><tr><td colspan=\"2\"><p align=\"center\"><strong>Review</strong></p></td></tr><tr><td><p align=\"center\"><strong>Meta-analysis</strong></p></td><td><ul><li>Data from multiple studies are statistically combined &amp; analyzed</li></ul></td></tr></tbody></table></div><p>The students conducted a <strong>cross-sectional</strong> survey where they inquired about possible risk factors (eg, carbonated beverage consumption) and outcomes (eg, obesity) at a <strong>specific</strong> point in time (&#x22;snapshot&#x22;).&nbsp; Cross-sectional studies are examples of <strong>observational</strong> studies.&nbsp; They are often relatively quick and easy to perform, are useful in determining prevalence of an outcome, and can serve to generate, but not test, hypotheses.</p><p><strong>(Choice A)</strong>&nbsp; In case-control studies, researchers begin by selecting patients with the disease/outcome of interest (eg, obesity) as cases and patients without the disease/outcome of interest as controls.</p><p><strong>(Choice B)</strong>&nbsp; The unit of analysis for ecological studies is <strong>populations</strong> rather than individuals.&nbsp; For example, ecological longitudinal studies using national data showed that lung cancer rates increased 2 decades after smoking rates increased.&nbsp; Although this suggested an association between smoking and lung cancer, the ecological studies did not link cases of lung cancers with individual smokers; case-control and cohort studies were needed to further study the association.</p><p><strong>(Choice C)</strong>&nbsp; Experimental (ie, interventional) studies would evaluate the impact of an intervention (eg, procedure, community-based intervention).&nbsp; Examples include randomized controlled trials.</p><p><strong>(Choice E)</strong>&nbsp; Prospective cohort studies follow subjects over time; this survey provided a snapshot at a given point in time.</p><p><strong>Educational objective:</strong><br>Cross-sectional studies are examples of observational studies.&nbsp; They are often relatively quick and easy to perform, are useful in determining prevalence of an outcome, and can serve to generate hypotheses.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19502,
            "topic": "Study designs",
            "titleId": 19502,
            "title": "Study designs",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 11523,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Case-control",
                    "choiceNumber": 1,
                    "correctTaken": 1054,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ecological longitudinal",
                    "choiceNumber": 2,
                    "correctTaken": 1345,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Experimental",
                    "choiceNumber": 3,
                    "correctTaken": 265,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observational",
                    "choiceNumber": 4,
                    "correctTaken": 8614,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prospective cohort",
                    "choiceNumber": 5,
                    "correctTaken": 585,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 5,
            "highlights": "1244,1292,true,-1,1*1508,1972,true,-1,1*407,442,true,-1,1*278,320,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 190,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 11863,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 644,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 11524,
            "questionIndex": 12685,
            "questionText": "<p><strong>Item 2 of 2</strong></p><p>The students subsequently mail out an anonymous questionnaire to members of the same community.&nbsp; The questionnaire is of similar length as the one administered during the fair, and the questions are phrased similarly.&nbsp; The response rate and the demographics of the sample are comparable to those of the survey taken at the fair.&nbsp; However, when the students analyze the data from the returned anonymous questionnaires, they find that the self-reported prevalence of obesity among household members is significantly higher than that estimated at the fair, and their results suggest that households with higher carbonated beverage consumption have a higher reporter prevalence of obesity.&nbsp; Which of the following forms of bias is most likely responsible for these differences in results?</p>",
            "questionHeader": "",
            "explanationText": "<p align=\"center\"><img draggable=\"false\" id=\"1380\" src=\"https://www.uworld.com/media/L17297.jpg\" ></p><p>Study participants may over- or under-report exposure history due to perceived social stigmatization, resulting in <strong>reporting bias</strong>.&nbsp; For example, while being interviewed directly by the students, the fairgoers may have under-reported carbonated beverage consumption and prevalence of obesity in their households due to concerns that they would be perceived negatively.&nbsp; In contrast, respondents to an anonymous mailed questionnaire may have provided more accurate data.</p><p>Other potential sources of bias in this situation include observer/interviewer bias, as the student interviewers may have inadvertently influenced the fairgoers&#39; responses by making gestures or emphasizing specific questions, and recall bias, as fairgoers may not have remembered the correct amount of carbonated beverages their household consumes (whereas participants filling out the mailed questionnaire at home may have found it easier to estimate or verify the correct amount).</p><p><strong>(Choices A and D)</strong>&nbsp; Ascertainment bias occurs when the results from an atypical population are extrapolated into the entire population; these study results have not been extrapolated to the population.&nbsp; In addition, the response rate and demographic characteristics of the survey and the mailed questionnaire were comparable, making nonresponse bias less likely.</p><p><strong>(Choice B)</strong>&nbsp; Berkson bias occurs when controls are chosen among hospitalized patients only, resulting in a potential bias (hospitalized controls may have had an exposure related to the outcome of interest) and limiting generalizability.</p><p><strong>(Choice C)</strong>&nbsp; Neyman bias occurs if exposure is a prognostic factor that can impact survival.&nbsp; Exposures that happen long before disease assessment can cause the study to miss diseased patients who die earlier.&nbsp; In rapidly fatal diseases, the impact can be even more extreme.&nbsp; For example, a hospital-based study on snow shoveling and myocardial infarction will miss patients who die in their driveways before reaching the hospital.</p><p><strong>Educational objective:</strong><br>Reporting bias may occur if subjects over- or under-report exposure history due to perceived social stigmatization.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24175,
            "topic": "Bias",
            "titleId": 24175,
            "title": "Bias",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 11523,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Ascertainment bias",
                    "choiceNumber": 1,
                    "correctTaken": 1128,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Berkson bias",
                    "choiceNumber": 2,
                    "correctTaken": 1256,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neyman bias",
                    "choiceNumber": 3,
                    "correctTaken": 459,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nonresponse bias",
                    "choiceNumber": 4,
                    "correctTaken": 858,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reporting bias",
                    "choiceNumber": 5,
                    "correctTaken": 8151,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 5,
            "highlights": "501,983,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "15252064",
                    "mediaDataId": 0,
                    "title": "Bias",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/15252064",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 82,
            "othersAvgTimeSpent": 46,
            "notes": null,
            "peopleTaken": 11852,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 681,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 19872,
            "questionIndex": 21361,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td id=\"vignettedescriptor\">The abstract shown on the left applies to the next <strong>2</strong> items.</td></tr></tbody></table><p>A 46-year-old woman comes to the office for follow-up of type 2 diabetes mellitus.&nbsp; The patient has been following a standard diabetic diet and the same oral antidiabetic agent regimen for the past 8 months.&nbsp; BMI is 25.2 kg/m<font size=\"2\"><sup>2</sup></font>, waist circumference is 83 cm, and hemoglobin A1c (HbA1c) is 7.3%.&nbsp; The patient recently read an article comparing a vegan diet to a standard diabetic diet in control of HbA1c levels.&nbsp; An excerpt from the study abstract is shown.</p><p><strong>Item 1 of 2</strong></p><p>Based on the abstract, which of the following conclusions is most appropriate?</p>",
            "questionHeader": "",
            "explanationText": "<p>This study compared the effects of a vegan diet to a standard diabetic diet on glycemic control in select patients with type 2 diabetes mellitus.&nbsp; The endpoints of the study were change in hemoglobin A1c (HbA1c) level over 12 weeks (primary endpoint) and changes in BMI, waist circumference, and other variables (secondary endpoints).&nbsp; Negative values for the changes (eg, &#8722;0.5) represent reductions;&nbsp;the standard deviations (eg, &plusmn;0.8) describe&nbsp;the spread of the changes (note that, even though some of the standard deviation values&nbsp;<strong>cross 0</strong>, they&nbsp;do <strong>not</strong> help determine statistical significance because they reflect spread and are&nbsp;<strong>NOT</strong> confidence intervals).</p><p>According to the footnote in the table,&nbsp;<em>p</em>-values &lt; 0.01 for paired <em>t</em>-tests were considered statistically significant.</p><p>Based on the abstract:</p><ul><li><strong>HbA1c</strong> levels were <strong>significantly reduced</strong> in both the vegan and the standard groups (<em>p</em> &lt; 0.01 for change in HbA1c in both groups), with a greater reduction in the vegan group (&#8722;0.5 &plusmn; 0.8) compared to the standard group (&#8722;0.2 &plusmn; 0.7).&nbsp; Among participants with &#8805;90% compliance, the reductions in HbA1c levels were even larger&nbsp;(&#8722;0.9 in the vegan group, &#8722;0.3 in the standard group) <strong>(Choice D)</strong>.&nbsp; The <em>p-</em>values comparing the reductions between the 2 diet groups were statistically significant, regardless of compliance.</li></ul><ul><li><strong>BMI</strong> was <strong>significantly reduced</strong> (<em>p</em> &lt; 0.01) in the vegan group only.&nbsp; Compared to the standard group (&#8722;0.1 &plusmn; 0.6), the <strong>vegan group</strong> had a <strong>greater reduction in BMI</strong> (&#8722;0.5 &plusmn; 0.9) at 12 weeks.</li></ul><ul><li><strong>Waist circumference</strong> was <strong>significantly reduced</strong> (<em>p</em> &lt; 0.01) in the <strong>vegan group only</strong>.&nbsp; Compared to the standard group (&#8722;0.8 &plusmn; 4.6), the vegan group had a greater reduction in waist circumference (&#8722;3.1 &plusmn; 4.9).</li></ul><p>Although both diets led to reductions in HbA1c levels, only the vegan diet helped to significantly reduce BMI and waist circumference.</p><p><strong>(Choice A)</strong>&nbsp; Although the baseline waist circumference values were 84.0 &plusmn; 9.8 in the vegan group and 82.3 &plusmn; 7.5 in the standard group, these differences likely are not statistically significant given how close these means are to each other and the magnitude of the standard deviation in each group (ie, vegan group 9.8 vs standard group 7.5).</p><p><strong>(Choice C)</strong>&nbsp; The vegan diet produced clinically significant reductions in HbA1c (eg, &#8722;0.5, &#8722;0.9), similar to those that can be achieved with pharmacotherapy.</p><p><strong>Educational objective:</strong><br>Statistically significant changes are reflected by a <em>p</em>-value less than a given significance level (eg, <em>p</em> &lt; 0.01).</p>",
            "abstractId": 3942,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24197,
            "topic": "Statistical vs. clinical significance",
            "titleId": 24197,
            "title": "Statistical vs. clinical significance",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "2",
            "userAnswer": "4",
            "parentQuestionId": 19872,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Baseline difference in waist circumference between the participants in the vegan and the standard diabetic diet groups makes comparisons unreliable",
                    "choiceNumber": 1,
                    "correctTaken": 524,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Compared to participants in the standard diabetic diet group, participants in the vegan diet group had a greater, statistically significant reduction in BMI",
                    "choiceNumber": 2,
                    "correctTaken": 6532,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "None of the differences between Week 0 and Week 12 reported in the abstract demonstrates any clinical significance",
                    "choiceNumber": 3,
                    "correctTaken": 2328,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Only participants with &#8805;90% compliance who followed a vegan diet showed a statistically significant decrease in HbA1c level at 12 weeks",
                    "choiceNumber": 4,
                    "correctTaken": 2240,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 3,
            "highlights": "502,643,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 354,
            "othersAvgTimeSpent": 156,
            "notes": null,
            "peopleTaken": 11637,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1388,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 19873,
            "questionIndex": 21362,
            "questionText": "<p><strong>Item 2 of 2</strong></p><p>Which of the following recommendations is appropriate for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>The <strong>applicability</strong> of study results beyond the specific population studied depends on whether <strong>particular patients</strong> are <strong>similar to those studied</strong>.&nbsp; This patient is a 46-year-old woman who has type 2 diabetes mellitus, a BMI of 25.2 kg/m<font size=\"2\"><sup>2</sup></font>, and an HbA1c level of 7.3%; she has been following a standard diabetic diet and antidiabetic agent regimen for the past 8 months.&nbsp; Based on the <strong>inclusion</strong> (ie, age 30-70; taking oral antidiabetic agents for &#8805;6 months; HbA1c level of 6%-10%) and <strong>exclusion</strong> (ie, increase in dose of antidiabetic agent or addition of new antidiabetic agent in past 3 months; current vegetarian; chronic renal failure) criteria described in the abstract, the study results may apply to her.</p><p>The study demonstrated that a <strong>vegan diet</strong> may be <strong>more helpful</strong> than a standard diabetic diet in <strong>decreasing HbA1c level</strong>, particularly among patients with a high (&#8805;90%) compliance.&nbsp; However, only <strong>15 of 59 (~25%)</strong> of participants <strong>achieved &#8805;90% compliance</strong> in the vegan group.&nbsp; Therefore, although a vegan diet likely would be beneficial to reduce this patient&#39;s HbA1c level, <strong>compliance may be difficult</strong>.</p><p><strong>(Choice A)</strong>&nbsp; The adequate follow-up time in a study depends on various factors, including the time required to observe a sufficiently large effect (eg, change in HbA1c level) in a study group to make valid statistical inferences (eg, 12-week follow-up chosen because HbA1c measures 3-month blood glucose averages).&nbsp; Although a longer follow-up period may potentially clarify effect duration and identify longterm side effects, study reproducibility (ie, in similar conditions) is not&nbsp;likely to be affected by a limited follow-up period.</p><p><strong>(Choice B)</strong>&nbsp; Although blinding is commonly used in experimental studies to control for bias, there are some instances in which blinding participants is impossible, as in interventions consisting of diet regimens or surgery.</p><p><strong>(Choice C)</strong>&nbsp; Although BMI was not a criterion used to include or exclude participants in the study, having a BMI close to the study&#39;s baseline values helps make a better application of study results.&nbsp; The patient&#39;s BMI (25.2 kg/m<font size=\"2\"><sup>2</sup></font>) is within the range of the baseline BMI values in the study (eg, 23.9 &plusmn; 3.4); therefore, it does not suggest that the study results would not apply.</p><p><strong>Educational objective:</strong><br>The applicability of study results beyond the specific population studied depends on whether particular patients are similar to those studied.&nbsp; Compliance to treatments can be an important factor.</p>",
            "abstractId": 3942,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 30875,
            "topic": "Evidence-based clinical recommendations",
            "titleId": 30875,
            "title": "Evidence-based clinical recommendations",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 19872,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "A vegan diet cannot be recommended because the study&#39;s limited follow-up period means that the results are not reproducible",
                    "choiceNumber": 1,
                    "correctTaken": 866,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "A vegan diet cannot be recommended because the study&#39;s participants were not adequately blinded to the assigned diet",
                    "choiceNumber": 2,
                    "correctTaken": 1579,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Although a vegan diet helped with weight loss in this study, the results may not apply to the patient given her BMI",
                    "choiceNumber": 3,
                    "correctTaken": 1253,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Although a vegan diet may be more helpful than a standard diabetic diet in decreasing HbA1c level, the patient may find compliance difficult",
                    "choiceNumber": 4,
                    "correctTaken": 7912,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 3,
            "highlights": "921,1130,true,-1,1*1364,1444,true,-1,1*1759,1889,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 92,
            "othersAvgTimeSpent": 44,
            "notes": null,
            "peopleTaken": 11610,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 737,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 3909,
            "questionIndex": 3909,
            "questionText": "<p>A prospective cohort study was conducted to evaluate the long-term effects of a high-fat diet on the incidence of colon cancer.&nbsp; The study participants were randomly selected from the population of interest.&nbsp; Dietary patterns were assessed through the use of periodic self-completed questionnaires.&nbsp; The investigators reported a 5-year relative risk of 1.60 for people who consumed a high-fat diet compared to individuals who consumed a low-fat diet.&nbsp; The 95% confidence interval was 1.02 to 2.15.&nbsp; This study is most likely to have which of the following <em>p</em> values?</p>",
            "questionHeader": "",
            "explanationText": "<p>Relative risk (RR) is the probability of the outcome of interest occurring in the exposed group compared to the probability of it occurring in the non-exposed group.&nbsp; The null value of the RR is 1.0; a RR of 1.0 means that the outcome occurs with equal frequency in both groups and that there is no association between the exposure and the outcome.&nbsp; A RR &gt; 1.0 means that the outcome occurs more frequently in the exposed group (positive association).&nbsp; The RR says nothing about the statistical significance of a study.</p><p>Statistical significance can be expressed with either <em>p</em> values or confidence intervals, but both are interrelated.&nbsp; For instance, <em>p</em> &lt; 0.05 corresponds to a 95% confidence interval that does not contain the null value.&nbsp; Likewise <em>p</em> &lt; 0.01 is equivalent to a 99% confidence interval that does not contain the null value.&nbsp; Conversely, if the null value is within a given confidence interval, then the <em>p</em> value is <u>&gt;</u> the equivalent confidence interval.</p><P><img id=\"7173\"  src=\"https://www.uworld.com/media/L12634.jpg\" draggable=\"false\" ></P><p>In general, for study results to be statistically significant, the 95% confidence interval must <strong>not </strong>contain the null value.&nbsp; This is equivalent to <em>p</em> &lt; 0.05, which means that there is less than a 5% chance that the results are due to chance alone.&nbsp; In this case, the 95% confidence interval is 1.02 to 2.15 and does not contain the null value of 1.0.&nbsp; This corresponds to <em>p</em> &lt; 0.05, thus 0.04 is the only correct answer choice.</p><p><strong>(Choices B, C, D, and E)</strong>&nbsp; These <em>p</em> values are all &gt; 0.05, meaning the associated 95% confidence interval would contain the null value.</p><p><strong>Educational objective:</strong><br>Confidence intervals and <em>p</em> values are interrelated and express the statistical significance of a study.&nbsp; In a statistically significant study, <em>p</em> should be &lt; 0.05.&nbsp; This corresponds to a 95% confidence interval that does not include the null value.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 20684,
            "topic": "Risk",
            "titleId": 20684,
            "title": "Risk",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "0.04",
                    "choiceNumber": 1,
                    "correctTaken": 94849,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "0.06",
                    "choiceNumber": 2,
                    "correctTaken": 6749,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "0.09",
                    "choiceNumber": 3,
                    "correctTaken": 4119,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "0.11",
                    "choiceNumber": 4,
                    "correctTaken": 2642,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "0.20",
                    "choiceNumber": 5,
                    "correctTaken": 3675,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "483,549,true,-1,1*1122,1243,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 109,
            "othersAvgTimeSpent": 40,
            "notes": null,
            "peopleTaken": 112034,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 85,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 481,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 7686,
            "questionIndex": 7686,
            "questionText": "<table border=\"0\" cellpadding=\"5\" cellspacing=\"0\" width=\"100%\"><tbody><tr><td bgcolor=\"#c0c0c0\" width=\"100%\">The drug ad applies to the next <strong>2</strong> items</td></tr></tbody></table><p>The drug advertisement is focused on kalgatran (Kalaxin), a new oral anticoagulant for the treatment of non-valvular atrial fibrillation.</p><p><strong>Item 1 of 2</strong></p><p>Bleeding risk is the major concern when anticoagulating patients with non-valvular atrial fibrillation.&nbsp; The advertisement promotes Kalaxin as a safe medication.&nbsp; In the study comparing Kalaxin and warfarin, which of the following specific bleeding risks were most similar between the 2 groups?</p>",
            "questionHeader": "",
            "explanationText": "<p>The drug advertisement is comparing the effect of Kalaxin versus warfarin for preventing stroke in non-valvular atrial fibrillation.&nbsp; It compares the hazard rates for adverse events for both drugs in the form of hazard ratios.&nbsp; A hazard rate is the chance of an event occurring in one of the study groups during a set period.&nbsp; A hazard ratio is the chance of an event occurring in the treatment group compared to the chance of that event occurring in the control group during a set period.</p><p>A hazard ratio &lt;1 indicates that an event is more likely to occur in the control group.&nbsp; A hazard ratio &gt;1 signifies that an event is more likely to occur in the treatment group.&nbsp; A ratio close to 1 implies little difference between the 2 groups.&nbsp; In this study, the hazard ratio for <a href=\"1128\">major bleeding</a> was 0.96, which is the closest to 1 compared to the other answer options.&nbsp; In addition, the 95% confidence interval (0.84-1.10) contains the null value of 1, indicating that there is no significant difference in the risk of major bleeding between the 2 groups.&nbsp; This information is presented in the text below the bar graph.&nbsp; As with any commercial entity, drug manufacturers may have incentive to maximize the visibility of a drug&#39;s benefits over its risks or side effects.&nbsp; As a result, it is important to critically read all presented information when reviewing a drug advertisement.</p><p><strong>(Choice A)</strong>&nbsp; The hazard ratio for <a href=\"1130\">gastrointestinal bleeding</a> is 1.75, indicating that Kalaxin has a higher chance of causing gastrointestinal bleeding than warfarin.&nbsp; The hazard ratio for <a href=\"1133\">major gastrointestinal bleeding</a> is 1.38.</p><p><strong>(Choice B)</strong>&nbsp; The hazard ratio for <a href=\"1131\">intracranial bleeding</a> is 0.39, indicating that Kalaxin has a lower chance of causing intracranial bleeding than warfarin.</p><p><strong>(Choice C)</strong>&nbsp; The hazard ratio for <a href=\"1132\">life-threatening bleeding</a> is 0.75, indicating that Kalaxin has a lower chance of causing life-threatening bleeding than warfarin.</p><p><strong>(Choice E)</strong>&nbsp; The hazard ratio for <a href=\"1129\">total bleeding</a> is 0.91, indicating that Kalaxin has a slightly lower chance of causing overall bleeding than warfarin.</p><p><strong>Educational objective:</strong><br>Hazard ratios are proportions that indicate the chance of an event occurring in the treatment group compared to the chance of the event occurring in the control group.&nbsp; When reviewing a drug advertisement, it is important to critically read all the presented information.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 15219,
            "topic": "Randomized control trials",
            "titleId": 15219,
            "title": "Randomized control trials",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 7686,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Gastrointestinal bleeding",
                    "choiceNumber": 1,
                    "correctTaken": 7753,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Intracranial bleeding",
                    "choiceNumber": 2,
                    "correctTaken": 9753,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Life-threatening bleeding",
                    "choiceNumber": 3,
                    "correctTaken": 27800,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major bleeding",
                    "choiceNumber": 4,
                    "correctTaken": 42826,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Total bleeding",
                    "choiceNumber": 5,
                    "correctTaken": 23167,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 2,
            "highlights": "698,767,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": {
                "id": 296,
                "fileName": "L18033.jpg;L18034.jpg;L18035.jpg",
                "typeId": 1,
                "title": "Kalaxin",
                "sequenceId": 1,
                "active": true,
                "baseUrl": "https://apps.uworld.com/media/"
            },
            "timeSpent": 137,
            "othersAvgTimeSpent": 91,
            "notes": null,
            "peopleTaken": 111299,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 38,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 860,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 7687,
            "questionIndex": 7687,
            "questionText": "<p><strong>Item 2 of 2</strong></p><p>When assigning patients to treatment and control groups, proper randomization is important to avoid the effect of extraneous variables in the study results.&nbsp; In the current study, which of the following forms of additional information would help most in determining randomization success?</p>",
            "questionHeader": "",
            "explanationText": "<p>In any randomized clinical study, the goal of successful randomization is to eliminate bias in treatment assignments.&nbsp; An ideal randomization process minimizes selection bias, results in near-equal treatment and control group sizes, and achieves a low probability of having confounding variables.&nbsp; A table of patient baseline characteristics for both treatment and control groups would show if the 2 groups included patients with similar features and would help confirm proper randomization.</p><p><strong>(Choice A)</strong>&nbsp; Annual stroke rate is an endpoint of the study that may be influenced by patient randomization, but it does not determine success of randomization.</p><p><strong>(Choice C)</strong>&nbsp; Patient compliance charts indicate how well a patient tolerated the treatment and followed the treatment regimen, but it would not directly indicate the success of randomization.</p><p><strong>(Choice D)</strong>&nbsp; Patient follow-up rates indicate how many patients followed up or dropped out of the study.&nbsp; These data are not a direct marker of randomization success.</p><p><strong>(Choice E)</strong>&nbsp; Subgroup analysis tables (stratified analysis) are used to determine if certain patient characteristics (eg, age, comorbidities) influenced treatment to any significant extent.&nbsp; Improper randomization can lead to inaccurate subgroup analysis results.</p><p><strong>Educational objective:</strong><br>Successful randomization in a clinical trial allows a study to eliminate bias in treatment assignments.&nbsp; An ideal randomization process minimizes selection bias, results in near-equal treatment and control group sizes, and achieves a low probability of confounding variables.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 15219,
            "topic": "Randomized control trials",
            "titleId": 15219,
            "title": "Randomized control trials",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 7686,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Annual stroke rates",
                    "choiceNumber": 1,
                    "correctTaken": 2345,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Baseline patient characteristics",
                    "choiceNumber": 2,
                    "correctTaken": 78713,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Patient compliance chart",
                    "choiceNumber": 3,
                    "correctTaken": 5553,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Patient follow-up rates",
                    "choiceNumber": 4,
                    "correctTaken": 5279,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Subgroup analysis tables",
                    "choiceNumber": 5,
                    "correctTaken": 18941,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 2,
            "highlights": "328,521,true,-1,1*1050,1301,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "3060315",
                    "mediaDataId": 0,
                    "title": "Statistical properties of randomization in clinical trials.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/3060315",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": {
                "id": 296,
                "fileName": "L18033.jpg;L18034.jpg;L18035.jpg",
                "typeId": 1,
                "title": "Kalaxin",
                "sequenceId": 1,
                "active": true,
                "baseUrl": "https://apps.uworld.com/media/"
            },
            "timeSpent": 116,
            "othersAvgTimeSpent": 34,
            "notes": null,
            "peopleTaken": 110831,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 608,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 18630,
            "questionIndex": 20103,
            "questionText": "<p>A 26-year-old primigravida woman comes to the office for a routine prenatal visit.&nbsp; The patient has Ehlers-Danlos syndrome (EDS) and is worried about her pregnancy.&nbsp; She read an article about pregnancy outcomes in women of similar age with EDS and wants to discuss the results.&nbsp; The study compared several perinatal events in women with EDS to those in women without EDS.&nbsp; A summary of the results is shown in the table below.</p><div id=\"div_T63456\"><table class=\"table-default-style\" style=\"width:100.0%\"><tbody><tr><td><p align=\"center\"><strong>Perinatal events</strong></p></td><td><p align=\"center\"><strong>Odds ratio*</strong></p></td><td><p align=\"center\"><strong>95% confidence interval</strong></p></td></tr><tr><td><p align=\"center\"><strong>Preterm birth</strong></p></td><td><p align=\"center\">0.6</p></td><td><p align=\"center\">0.2-2.8</p></td></tr><tr><td><p align=\"center\"><strong>Induction of labor</strong></p></td><td><p align=\"center\">2.9</p></td><td><p align=\"center\">1.9-4.6</p></td></tr><tr><td><p align=\"center\"><strong>Amniotomy</strong></p></td><td><p align=\"center\">3.5</p></td><td><p align=\"center\">2.0-6.2</p></td></tr><tr><td><p align=\"center\"><strong>Cesarean delivery</strong></p></td><td><p align=\"center\">0.8</p></td><td><p align=\"center\">0.3-1.6</p></td></tr><tr><td><p align=\"center\"><strong>Small-for-gestational-age birth</strong></p></td><td><p align=\"center\">1.2</p></td><td><p align=\"center\">0.4-5.2</p></td></tr><tr><td><p align=\"center\"><strong>Large-for-gestational-age birth</strong></p></td><td><p align=\"center\">1.4</p></td><td><p align=\"center\">0.5-4.6</p></td></tr><tr><td colspan=\"3\"><p>*Odds ratio adjusted for maternal age, smoking history, BMI, parity, and year of birth.</p></td></tr></tbody></table></div><p>Based on the study results, which of the following conclusions is strongly justified?</p>",
            "questionHeader": "",
            "explanationText": "<p>The <strong>odds ratio (OR)</strong> is a measure of association used in case-control studies to compare the <strong>odds of exposure</strong> in cases (ie, individuals with disease) relative to controls (ie, individuals without disease):</p><p>OR = (odds of exposure in cases) / (odds of exposure in controls)</p><p>The OR may be interpreted as follows:</p><ul><li><p>OR &lt;1.0 indicates that the exposure is associated with a decrease in odds of disease with respect to no exposure (ie, the exposure is a protective factor).</p></li><li><p>OR = 1.0 (null value) indicates that there is no association between the exposure and the disease.</p></li><li><p><strong>OR &gt;1.0</strong> indicates that the exposure is associated with an <strong>increase in odds</strong> of disease with respect to no exposure (ie, the exposure is a <strong>risk factor</strong>).</p></li></ul><p>The <strong>confidence interval</strong> (CI) of an OR indicates, with a certain confidence level, whether a given OR is statistically different from the <strong>null value</strong> (ie, OR = 1.0).&nbsp; A CI that includes the null value is not statistically significant, and a CI that <strong>excludes</strong> the null value is <strong>statistically significant</strong> (at that confidence level).</p><p>In this study, results show that Ehlers-Danlos syndrome (EDS) <strong>increases the odds</strong> of <strong>amniotomy</strong> because OR &gt;1.0; the change (OR = 3.5 compared to OR = 1) represents an increase of 250% ([3.5 &#8722; 1]/1 = 2.5 = 250%), with a 95% CI: 2.0-6.2.&nbsp; The calculations are based on the principle that an OR = 1 (null value) does not increase the odds (ie, OR = 1 corresponds to a 0% change in odds), so an OR = 2 increases odds by 100% (not 200%), and so on.&nbsp; Similarly, EDS also increases the odds of induction of labor by 190%, or about 200% (OR = 2.9 compared to OR = 1; 95% CI: 1.9-4.6) <strong>(Choice D)</strong>.&nbsp; Because neither CI includes the null value (ie, OR = 1.0), these associations are statistically significant<strong> (Choice E)</strong>.</p><p><strong>(Choices A and C)</strong>&nbsp; EDS does not appear to be significantly associated with preterm birth (OR = 0.6; 95% CI: 0.2-2.8), cesarean delivery (OR = 0.8; 95% CI: 0.3-1.6), small-for-gestational-age birth (OR = 1.2; 95% CI: 0.4-5.2), or large-for-gestational-age birth (OR = 1.4; 95% CI: 0.5-4.6) because each CI contains the null value of 1.0.</p><p><strong>Educational objective:</strong><br>The odds ratio (OR) is a measure of association between an exposure and a disease.&nbsp; For OR &lt;1.0, the exposure decreases the odds of disease (ie, protective factor).&nbsp; For OR = 1.0, there is no association between exposure and disease.&nbsp; For OR &gt;1.0, the exposure increases the odds of disease (ie, risk factor).&nbsp; Confidence intervals that contain the null value (ie, OR =1.0) indicate that the association is not statistically significant.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 29979,
            "topic": "Measures of association",
            "titleId": 29979,
            "title": "Measures of association",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "2",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "EDS is a protective factor for preterm birth and cesarean delivery",
                    "choiceNumber": 1,
                    "correctTaken": 524,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "EDS significantly increases the odds of amniotomy by about 250%",
                    "choiceNumber": 2,
                    "correctTaken": 5604,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Small- and large-for-gestational-age births are more likely in women with EDS than in women without EDS",
                    "choiceNumber": 3,
                    "correctTaken": 1130,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The odds of induction of labor are about 30% higher in women with EDS than in women without EDS",
                    "choiceNumber": 4,
                    "correctTaken": 2650,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is no significant difference in perinatal events between women with and without EDS",
                    "choiceNumber": 5,
                    "correctTaken": 631,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1076,1783,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 151,
            "othersAvgTimeSpent": 107,
            "notes": null,
            "peopleTaken": 10539,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 501,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 23882,
            "questionIndex": 108162,
            "questionText": "<p>An observational study was conducted to evaluate the association between exposure to a certain hazardous chemical and cancer.&nbsp; The study population included individuals who were employees of a chemical company when the company had a chemical accident 10 years ago.&nbsp; Company records were used to identify potential participants.&nbsp; Individuals enrolled in the study were categorized by their level of exposure to the hazardous chemical: no exposure, minimal exposure, moderate exposure, or severe exposure.&nbsp; Databases were used to determine the status (cancer, cancer free) of employees in each group.&nbsp; The number of cancer cases for each level of exposure was as follows:</p><ul><li>No exposure (n = 200): 10 cases</li><li>Minimal exposure (n = 120): 12 cases</li><li>Moderate exposure (n = 160): 28 cases</li><li>Severe exposure (n = 120): 40 cases</li></ul><p>Which of the following expressions would provide a value closest to the relative risk of developing cancer for employees with at least a minimal level of exposure compared to nonexposed employees?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Relative risk (RR)</strong> is used in cohort studies to estimate the association between exposure and disease.&nbsp; It compares <strong>risk of disease</strong> (eg, cancer) in an <strong>exposed</strong> group (eg, exposure to a hazardous chemical) relative to a <strong>nonexposed</strong> group (eg, no exposure to a hazardous chemical).&nbsp; The RR can be calculated based on the incidence of disease in the exposed group divided by the incidence of disease in the nonexposed group.</p><div class=\"equation-scroll\"><p style=\"text-align:center; width:600px;\">RR = (incidence in exposed group) / (incidence in nonexposed group)</p></div><p>Using the results from this study, the RR of cancer can be determined for employees with at least a minimal level of exposure compared to nonexposed employees.&nbsp; The <strong>exposed group</strong> includes <strong>3 exposure levels</strong> (ie, minimal, moderate, severe), and the <strong>nonexposed group</strong> includes <strong>1 exposure level</strong> (ie, no exposure).&nbsp; The incidence of cancer for exposed and nonexposed groups is calculated as follows:</p><ul><li><p>The <strong>exposed</strong> group consisted of 400 (= 120 + 160 + 120) employees with at least a minimal level of exposure, of which 80 (= 12 + 28+ 40) had cancer, for an <strong>incidence of 80 / 400</strong>.</p></li><li><p>The <strong>nonexposed</strong> group consisted of 200 employees with no exposure, of which 10 had cancer, for an <strong>incidence of 10 / 200</strong>.</p></li></ul><p>Therefore, the expression that would provide the RR of developing cancer for employees with at least a minimal level of exposure compared to nonexposed employees is:</p><p style=\"text-align:center;\">RR = (80 / 400) / (10 / 200)</p><p><strong>(Choice A)</strong>&nbsp; The expression (80 / 400) &#8722; (10 / 200) provides the risk difference for cancer between employees with at least a minimal level of exposure and nonexposed employees.</p><p><strong>(Choices B and E)</strong>&nbsp; These expressions, (10 &times; 320) / (80 &times; 190) and (80 &times; 190) / (10 &times; 320), provide odds ratios (ORs).&nbsp; The first gives the OR of cancer for at least a minimal level of exposure relative to no exposure, and the second gives the OR for no exposure relative to at least a minimal level of exposure.</p><p><strong>(Choice C)</strong>&nbsp; The expression (10 / 200) / (80 / 400) provides the RR of cancer for nonexposed employees compared to employees with at least a minimal level of exposure.</p><p><strong>Educational objective:</strong><br>Relative risk (RR) is a measure of association used to compare the incidence of disease in an exposed group relative to a nonexposed group.&nbsp; It is calculated as:</p><div class=\"equation-scroll\"><p style=\"text-align:center; width:600px;\">RR = (incidence in exposed group) / (incidence in nonexposed group)</p></div>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 20684,
            "topic": "Risk",
            "titleId": 20684,
            "title": "Risk",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "(80 / 400) &#8722; (10 / 200)",
                    "choiceNumber": 1,
                    "correctTaken": 722,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "(10 &times; 320) / (80 &times; 190)",
                    "choiceNumber": 2,
                    "correctTaken": 332,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "(10 / 200) / (80 / 400)",
                    "choiceNumber": 3,
                    "correctTaken": 1178,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "(80 / 400) / (10 / 200)",
                    "choiceNumber": 4,
                    "correctTaken": 8048,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "(80 &times; 190) / (10 &times; 320)",
                    "choiceNumber": 5,
                    "correctTaken": 360,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "939,976,true,0,1*1603,1895,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 709,
            "othersAvgTimeSpent": 113,
            "notes": null,
            "peopleTaken": 10640,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 813,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 4001,
            "questionIndex": 4001,
            "questionText": "<p>A clinical study is conducted to assess the role of a vasopressin antagonist in overall survival of patients with advanced heart failure and hyponatremia.&nbsp; After providing informed consent, eligible hospitalized patients are administered either the new drug or a matching placebo along with the appropriate standard care.&nbsp; Assignment to the 2 treatment arms is done randomly using computer-generated numbers.&nbsp; This assignment strategy is most helpful for controlling which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<P><img id=\"7187\"  src=\"https://www.uworld.com/media/L12635.jpg\" draggable=\"false\" ></P><p>The effects of <strong>confounding</strong> bias can be reduced through good study design and proper analysis of the results.&nbsp; Methods used to control for confounding during data analysis include stratified analysis and statistical modeling (eg, multivariate analyses).&nbsp; In addition, methods to control for confounders during study design include the following:</p><ol><li>Matching: Frequently used in case-control studies, this method involves matching known or suspected confounding variables between the cases and controls.&nbsp; For example, if smoking status is a known confounder, then controls will be selected on a case-by-case basis so that there are similar numbers of smokers and nonsmokers in both the case and control groups.</li><li>Restriction: This method involves limiting study participation to individuals with specific characteristics.&nbsp; For example, if sex is thought to be a confounder, then a restricted study may enroll only men.&nbsp; However, this method is limited as the study results may not be applicable to the excluded population (ie, women).</li><li><strong>Randomization</strong>: Commonly employed in clinical trials, this technique helps to balance the distribution of confounding variables between treatment and placebo groups so that the unconfounded effect of the exposure of interest can be isolated.&nbsp; An important advantage of randomization, compared to other methods, is the possibility of controlling known risk factors (eg, age and severity of heart failure) as well as the unknown and difficult-to-measure confounders (eg, level of stress and socioeconomic status).</li></ol><p>Randomization also eliminates partiality in treatment assignments, minimizing selection bias.</p><p><strong>(Choice B)</strong>&nbsp; Effect modification results when an external variable positively or negatively impacts the effect of a risk factor on the disease of interest.&nbsp; For instance, the risk of venous thrombosis is increased with estrogen therapy, and this effect is augmented by smoking.</p><p><strong>(Choice C)</strong>&nbsp; Post-hoc analysis refers to performing unplanned statistical tests on patterns that were identified after the fact in data from a completed study.&nbsp; This can lead to incorrect conclusions, particularly if the appropriate statistical measures have not been taken to account for these additional tests.&nbsp; Post-hoc analysis can be problematic with non-predefined subgroup analysis.&nbsp; Randomization does not directly impact post-hoc analysis (which can be conducted even on data from randomized samples).</p><p><strong>(Choice D)</strong>&nbsp; Recall bias results from inaccurate recall of past exposure and applies primarily to retrospective studies.&nbsp; People who have suffered an adverse event are more likely to recall risk factors than people without such experiences.</p><p><strong>(Choice E)</strong>&nbsp; Selective survival bias occurs in case-control studies when cases are selected from the entire disease population instead of just those that are newly diagnosed.&nbsp; For instance, a study on cancer survival that is not limited to newly diagnosed patients will contain a higher proportion of relatively benign malignancies as these patients generally live longer.</p><p><strong>Educational objective:</strong><br>Randomization is used to control for confounders during the design stage of a study.&nbsp; It helps to control for known, unknown, and difficult-to-measure confounders.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 6409,
            "topic": "Confounding, effect modification, bias, errors",
            "titleId": 6409,
            "title": "Confounding, effect modification, bias, errors",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "1",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Confounding",
                    "choiceNumber": 1,
                    "correctTaken": 49688,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Effect modification",
                    "choiceNumber": 2,
                    "correctTaken": 14107,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Post-hoc analysis",
                    "choiceNumber": 3,
                    "correctTaken": 6515,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recall bias",
                    "choiceNumber": 4,
                    "correctTaken": 2690,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Selective survival",
                    "choiceNumber": 5,
                    "correctTaken": 22959,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "210,286,true,-1,1*377,529,true,-1,1*847,1059,true,-1,1*1301,1570,true,-1,1*1954,2451,true,-1,1*2704,3063,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "15252064",
                    "mediaDataId": 0,
                    "title": "Bias.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/15252064",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 286,
            "othersAvgTimeSpent": 52,
            "notes": null,
            "peopleTaken": 95959,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1147,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 23361,
            "questionIndex": 107550,
            "questionText": "<p>A 7-year-old boy is admitted to the pediatric intensive care unit (PICU) due to clinical suspicion for sepsis.&nbsp; The patient&#39;s parents agree to let him participate in an ongoing clinical study to assess the utility of IL-27 in predicting bacterial infection among patients with bloodstream infections who are admitted to the PICU.&nbsp; A blood sample is obtained and reveals an IL-27 value of 5 ng/mL.&nbsp; A previously published study that compared several cut points for IL-27 with positive blood cultures showed that an IL-27 value &#8805;5 ng/mL has a sensitivity of 26% and a specificity of 95%.&nbsp; In considering how this patient&#39;s IL-27 value might influence treatment decisions, which of the following conclusions about the study results is correct?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t32272\"><table class=\"table-default-style table-header-footer-style\" style=\"width:82.36%\"><tbody><tr><td style=\"width:30.36%; border:none;\"></td><td style=\"width:24.2%;\"><p align=\"center\"><strong>Positive condition</strong></p></td><td style=\"width:24.36%;\"><p align=\"center\"><strong>Negative condition</strong></p></td><td style=\"width:24.36%; border:none;\"></td></tr><tr><td style=\"width:30.36%;\"><p align=\"center\"><strong>Positive test result</strong></p></td><td style=\"width:24.2%;\"><p align=\"center\">TP</p></td><td style=\"width:24.36%;\"><p align=\"center\">FP</p></td><td style=\"width:24.36%;\"><p align=\"center\">PPV =<br />TP / (TP + FP)</p></td></tr><tr><td style=\"width:30.36%\"><p align=\"center\"><strong>Negative test result</strong></p></td><td style=\"width:24.2%\"><p align=\"center\">FN</p></td><td style=\"width:24.36%\"><p align=\"center\">TN</p></td><td style=\"width:24.36%\"><p align=\"center\">NPV =<br />TN / (TN + FN)</p></td></tr><tr><td style=\"width:30.36%; border:none;\"></td><td style=\"width:24.2%;\"><p align=\"center\">Sensitivity =</p><p align=\"center\">TP / (TP + FN)</p></td><td style=\"width:24.36%;\"><p align=\"center\">Specificity =</p><p align=\"center\">TN / (TN + FP)</p></td><td style=\"width:24.36%; border:none;\"></td></tr><tr><td colspan=\"4\" style=\"width:100.0%;\"><p><strong>FN</strong> = false negative; <strong>FP</strong> = false positive; <strong>NPV</strong> = negative predictive value; <strong>PPV</strong> = positive predictive value; <strong>TN</strong> = true negative; <strong>TP</strong> = true positive.</p></td></tr></tbody></table></div><p>Compared to blood culture (the reference standard for diagnosing bacterial bloodstream infection), an IL-27 cut point of &#8805;5 ng/mL has a <strong>sensitivity of 26%</strong> and a <strong>specificity of 95%</strong>.</p><ul><li><p>The <strong>specificity</strong> of the test is the percentage of individuals (eg, critically ill pediatric patients) without a condition (eg, bacterial bloodstream infection) who are correctly identified (ie, negative test result) by the diagnostic test.&nbsp; Its <strong>complement</strong> (100% &#8722; specificity) is the <strong>false-positive rate</strong> (eg, percentage of critically ill pediatric patients without bacterial bloodstream infection who test positive).</p></li><li><p>The sensitivity of the test is the percentage of individuals (eg, critically ill pediatric patients) with a condition (eg, bacterial bloodstream infection) who are correctly identified (ie, positive test result) by the diagnostic test.&nbsp; Its complement (100% &#8722; sensitivity) is the false-negative rate (eg, percentage of critically ill pediatric patients with bacterial bloodstream infection who test negative).</p></li></ul><p>The <strong>specificity</strong> of 95% means that <strong>95%</strong> of critically ill pediatric patients without bacterial bloodstream infection will be <strong>correctly identified</strong> (ie, test negative) based on the IL-27 cut point of &#8805;5 ng/mL (ie, test result &lt;5 ng/mL).&nbsp; Conversely, 100% &#8722; 95% = <strong>5%</strong> will be <strong>incorrectly identified</strong> (ie, false-positive rate) (Choice D).</p><p>The sensitivity of 26% means that 26% of critically ill pediatric patients with bacterial bloodstream infection will be correctly diagnosed (ie, test positive) based on the IL-27 cut point of &#8805;5 ng/mL <strong>(Choices A and C)</strong>.&nbsp; Therefore, 100% &#8722; 26% = 74% of patients with bacterial bloodstream infection will be missed (ie, test negative with a result &lt;5 ng/mL) <strong>(Choices E and F)</strong>.</p><p><strong>Educational objective:</strong><br>Sensitivity represents the probability that an individual with disease will have a positive test result.&nbsp; Specificity represents the probability that an individual without disease will have a negative test result.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24431,
            "topic": "Sensitivity and specificity",
            "titleId": 24431,
            "title": "Sensitivity and specificity",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "2",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Based on a cut point of &#8805;5 ng/mL, 5% of critically ill pediatric patients with bacterial bloodstream infections will be correctly identified",
                    "choiceNumber": 1,
                    "correctTaken": 259,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Based on a cut point of &#8805;5 ng/mL, 5% of critically ill pediatric patients without bacterial bloodstream infections will be incorrectly identified",
                    "choiceNumber": 2,
                    "correctTaken": 6110,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Based on a cut point of &#8805;5 ng/mL, 95% of critically ill pediatric patients with bacterial bloodstream infections will be correctly identified",
                    "choiceNumber": 3,
                    "correctTaken": 2774,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Based on a cut point of &#8805;5 ng/mL, 95% of critically ill pediatric patients without bacterial bloodstream infections will be incorrectly identified",
                    "choiceNumber": 4,
                    "correctTaken": 475,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Of all critically ill pediatric patients with bacterial bloodstream infections, 5% will have an IL-27 value &lt;5 ng/mL",
                    "choiceNumber": 5,
                    "correctTaken": 805,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Of all critically ill pediatric patients with bacterial bloodstream infections, 95% will have an IL-27 value &lt;5 ng/mL",
                    "choiceNumber": 6,
                    "correctTaken": 247,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "796,971,true,-1,1*1211,1382,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 186,
            "othersAvgTimeSpent": 122,
            "notes": null,
            "peopleTaken": 10670,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1440,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 20226,
            "questionIndex": 21722,
            "questionText": "<p>A group of scientists developed a new quantitative test to diagnose a childhood disease that is lethal if left untreated.&nbsp; The distribution of patients who have the disease and who are disease-free according to their values on the new test are shown below.</p><p><img  draggable=\"false\" id=\"49055\" src=\"https://www.uworld.com/media/highresdefault/L75285.png\"  ></p><p>If the treatment for the disease is safe and inexpensive, which of the points labeled on the graph represents the best diagnostic cutoff for the disease?</p>",
            "questionHeader": "",
            "explanationText": "<p>In this example, scientists developed a new quantitative test to diagnose a childhood <strong>disease</strong> that is <strong>lethal if left untreated</strong>.&nbsp; For this type of disease, the consequences of a <strong>false-negative</strong> diagnostic error are <strong>catastrophic</strong> because a patient incorrectly diagnosed as not having the disease will certainly die as a result.&nbsp; Therefore, the cutoff for diagnosis should be set at a point that guarantees that among all subjects with disease, the proportion who have a positive test result is as high as possible (ie, <strong>maximum sensitivity</strong>) given the safety and cost of available treatments.</p><p>The <strong>treatment</strong> for the disease under study is <strong>safe and inexpensive</strong>, which means that treating patients who are disease-free causes little to no harm.&nbsp; In this case, a false-positive diagnostic error (which may lead to inappropriate but safe and inexpensive treatment) is less consequential than a false-negative diagnostic error (which leads to death).&nbsp; Therefore, the <strong>best cutoff</strong> for the quantitative test would be a point that guarantees all patients who have the disease are correctly diagnosed (<strong>100% sensitivity</strong>).</p><p>On the graph given, the cutoff that guarantees 100% sensitivity is <strong>point B</strong>.&nbsp; If this point is selected as a cutoff, test values higher than B will be considered a positive test result.&nbsp; All patients with the disease have values higher than B; therefore, they will all be correctly diagnosed as having the disease (100% sensitivity).&nbsp; Similarly, if points C, D, or E are selected as cutoff points, values higher than these will be considered a positive test but some patients with the disease will be missed (false negatives) <strong>(Choices D and E)</strong>.&nbsp; If point A is selected as a cutoff point, many patients without the disease will be incorrectly diagnosed as having the disease (false positives)&nbsp;<strong>(Choice A)</strong>.</p><p><strong>(Choice C)</strong>&nbsp; Point C also misses some patients with the disease (ie, those who have values lower than C).&nbsp; Given its location in the middle of the disease and disease-free symmetric curves, it represents the cutoff that results in the greatest diagnostic accuracy (ie, greatest proportion of patients with and without the disease are correctly identified).</p><p><strong>Educational objective:</strong><br>The cutoff of a test used to diagnose a lethal disease should guarantee the maximum sensitivity possible, considering the safety and cost of available treatments.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24431,
            "topic": "Sensitivity and specificity",
            "titleId": 24431,
            "title": "Sensitivity and specificity",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "A",
                    "choiceNumber": 1,
                    "correctTaken": 1165,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "B",
                    "choiceNumber": 2,
                    "correctTaken": 10422,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "C",
                    "choiceNumber": 3,
                    "correctTaken": 1553,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "D",
                    "choiceNumber": 4,
                    "correctTaken": 896,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "E",
                    "choiceNumber": 5,
                    "correctTaken": 771,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "617,1133,true,-1,1*1942,2192,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 137,
            "othersAvgTimeSpent": 39,
            "notes": null,
            "peopleTaken": 14807,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 508,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 18942,
            "questionIndex": 20423,
            "questionText": "<p>A group of researchers plans to conduct a case-control study to evaluate the association between colorectal cancer and evidence of past use of the weight-loss treatment drug lorcaserin.&nbsp; Which of the following corresponds with the proposed study design?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"6804\" src=\"https://www.uworld.com/media/L13767.jpg\" ></p><p>A <strong>case-control</strong> study is a type of analytical observational study design in which potential participants are <strong>initially identified</strong> as &#x22;cases&#x22; or &#x22;controls&#x22; according to an <strong>outcome status</strong> (ie, disease or condition of interest).&nbsp; In this question, individuals with colorectal cancer are cases and individuals without colorectal cancer are controls.&nbsp; Once identified, cases and controls are then assessed for <strong>past exposure to &#8805;1 risk factors</strong> of interest.</p><p>The risk factor is past use of the weight-loss treatment drug lorcaserin.&nbsp; The <strong>frequency of exposure</strong> to the risk factor is measured and <strong>compared between cases and controls</strong> to estimate the association between the risk factor and outcomes of interest.&nbsp; In other words, the frequency of prior lorcaserin use (ie, risk factor) should be compared among patients with (ie, cases) and without (ie, controls) colorectal cancer.</p><p><strong>(Choice A)</strong>&nbsp; A case-control study begins by identifying individuals based on outcome or disease status (eg, colorectal cancer), not risk factor status (eg, history of lorcaserin use).</p><p><strong>(Choice B)</strong>&nbsp; Controls without a history of lorcaserin use represent a portion of the control group.&nbsp; Excluding these individuals will result in a frequency of exposure to the risk factor (eg, history of lorcaserin use) of 100% in the control group, which is incorrect.</p><p><strong>(Choices C and E)</strong>&nbsp; A cohort study (not a case-control study) would begin by identifying individuals as exposed or nonexposed to a risk factor (eg, history of lorcaserin use) and end by comparing outcome rates (eg, cancer incidence) between the exposed and nonexposed groups.</p><p><strong>Educational objective:</strong><br>A case-control study is an observational study design.&nbsp; It begins with individuals who have the outcome (ie, cases) and compares them with individuals who do not have the outcome (ie, controls), according to a history of exposure to &#8805;1 risk factors.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19502,
            "topic": "Study designs",
            "titleId": 19502,
            "title": "Study designs",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cases should be identified as individuals with a history of lorcaserin use",
                    "choiceNumber": 1,
                    "correctTaken": 563,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Controls without a history of lorcaserin use should be excluded from the study",
                    "choiceNumber": 2,
                    "correctTaken": 170,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The frequency of colorectal cancer should be compared in individuals with and without a history of lorcaserin use at the beginning of the study",
                    "choiceNumber": 3,
                    "correctTaken": 2041,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The frequency of prior lorcaserin use should be compared among individuals with and without colorectal cancer",
                    "choiceNumber": 4,
                    "correctTaken": 7128,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The study should begin by identifying individuals based on their history of lorcaserin use",
                    "choiceNumber": 5,
                    "correctTaken": 726,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 129,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 10628,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 230,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 3960,
            "questionIndex": 3960,
            "questionText": "<p>A group of researchers conducted a prospective cohort study to evaluate the association between caffeine consumption and the risk of colon cancer in women.&nbsp; A total of 200 women age 40-60 participated in the study.&nbsp; The statistical analysis controlled for factors such as amount of caffeine consumed per day, caffeine consumption changes during follow-up time, and other factors related to both caffeine consumption and colon cancer.&nbsp; Results showed that caffeine consumption was associated with a statistically significant decrease in the risk of colon cancer with a relative risk of 0.83 (<em>p</em> = 0.02).&nbsp; Researchers concluded that women in general could significantly reduce the risk of colon cancer if they increased their caffeine consumption.&nbsp; Which of the following is most likely to invalidate the researchers&#39; conclusion?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t35807\"><table class=\"table-default-style\"><tbody><tr><td style=\"width:20.0%;\"></td><td style=\"width:40.0%;\"><p align=\"center\"><strong>Internal validity</strong></p></td><td style=\"width:40.0%;\"><p align=\"center\"><strong>External validity</strong></p></td></tr><tr><td rowspan=\"3\" style=\"width:20.0%\"><p align=\"center\"><strong>Characteristics</strong></p></td><td style=\"width:40.0%\"><p>Describes causality (ie, if change in independent variable causes change in dependent variable)</p></td><td style=\"width:40.0%\"><p>Describes generalizability (ie, if observed relationship applies to situations or people outside study)</p></td></tr><tr><td style=\"width:40.0%\"><p>&#8593; As study becomes more tightly controlled</p></td><td style=\"width:40.0%\"><p>&#8595; As study becomes more tightly controlled</p></td></tr><tr><td style=\"width:40.0%\"><p>&#8595; As study becomes more like the real world</p></td><td style=\"width:40.0%\"><p>&#8593; As study becomes more like the real world</p></td></tr><tr><td style=\"width:20.0%;\"><p align=\"center\"><strong>Threats to validity</strong></p></td><td style=\"width:40.0%;\"><p>Bias due to:</p><ul><li>Confounding</li><li>History</li><li>Maturation</li><li>Measurement</li><li>Regression toward the mean</li><li>Repeated testing</li><li>Selection</li></ul></td><td style=\"width:40.0%;\"><p>Bias due to:</p><ul><li>Artificial research environment</li><li>Measurement effects</li><li>Nonrepresentative sample</li></ul></td></tr></tbody></table></div><p>The <strong>external validity</strong> (or <strong>generalizability</strong>) of a study is the <strong>applicability</strong> of study <strong>results beyond</strong> the <strong>specific population</strong> studied.&nbsp; This cohort study evaluated the association between caffeine consumption and the risk of colon cancer in <strong>women age 40-60</strong> (ie, middle-aged women).&nbsp; Although study results showed that caffeine consumption was associated with a statistically significant decrease in the risk of colon cancer (ie, relative risk = 0.83; <em>p</em> = 0.02), it is unknown whether the association holds for other populations of women (eg, younger women age &lt;40, elderly women age &gt;60).&nbsp; Therefore, these study results <strong>may not apply to women in general</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Internal validity is concerned with how well results provide evidence of a causal relationship in a study; it is affected by bias (eg, confounding bias, selection bias).&nbsp; In this study, the statistical analysis controlled for potential confounders (ie, amount of caffeine consumed per day, caffeine consumption changes during follow-up time, other factors related to colon cancer) but no other description of how the study was designed or conducted was provided.&nbsp; Therefore, it is not possible to determine whether the internal validity was affected (ie, if bias is present).</p><p><strong>(Choices C and D)</strong>&nbsp; Reproducibility (reliability) refers to the extent to which a measure produces consistent results if the measurements are repeated multiple times.&nbsp; Information on how repeated measurements of variables (eg, caffeine consumption, changes in consumption) were collected over time is not provided, so it is not possible to determine whether the measurements were reproducible (reliable).</p><p><strong>(Choice E)</strong>&nbsp; Statistical power is the ability of a study to detect a significant association (eg, decrease in risk of colon cancer) when that association exists.&nbsp; This study was able to detect a statistically significant association between caffeine consumption and colon cancer, so the study had sufficient statistical power.</p><p><strong>Educational objective:</strong><br>The external validity (or generalizability) of a study is the applicability of results beyond the specific population studied.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 20447,
            "topic": "Validity And Reliability",
            "titleId": 20447,
            "title": "Validity And Reliability",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "1",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Generalizability",
                    "choiceNumber": 1,
                    "correctTaken": 7790,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Internal validity",
                    "choiceNumber": 2,
                    "correctTaken": 1777,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reliability",
                    "choiceNumber": 3,
                    "correctTaken": 707,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reproducibility",
                    "choiceNumber": 4,
                    "correctTaken": 1217,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Statistical power",
                    "choiceNumber": 5,
                    "correctTaken": 2591,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "82,102,true,-1,1*107,178,true,-1,1*490,586,true,-1,1*600,676,true,-1,1*1343,1918,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 97,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 14082,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1458,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 20301,
            "questionIndex": 21800,
            "questionText": "<p>A randomized controlled trial of drug X is performed in adult patients hospitalized with a severe viral respiratory tract infection.&nbsp; Drug X had previously been shown in vitro to inhibit cell entry of this specific virus.&nbsp; Based on a power analysis, 78 patients are enrolled in the trial, half of whom are randomized to the intervention arm (standard care + drug X) and the other half to the control arm (standard care).&nbsp; The outcome of the trial is viral load in the patients&#39; blood samples, obtained by daily PCR measurements.&nbsp; The percentage of patients with a positive viral load is compared between the groups.&nbsp; Data from 18 patients in the intervention group and 2 patients in the control group are not included in the final data analysis because these patients died from cardiopulmonary arrest.&nbsp; The results are summarized below:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td></td><td colspan=\"2\" style=\"vertical-align:middle;\">% of patients with positive viral load by PCR</td><td rowspan=\"2\" style=\"vertical-align:middle;\"><em>p</em>-value</td></tr><tr><td></td><td style=\"vertical-align: middle; text-align: center;\">Intervention group</td><td style=\"vertical-align: middle; text-align: center;\">Control group</td></tr><tr><td>Day 0</td><td style=\"text-align: center;\">100</td><td style=\"text-align: center;\">100</td><td style=\"text-align: center;\">0.36</td></tr><tr><td>Day 1</td><td style=\"text-align: center;\">94</td><td style=\"text-align: center;\">90</td><td style=\"text-align: center;\">0.12</td></tr><tr><td>Day 2</td><td style=\"text-align: center;\">82</td><td style=\"text-align: center;\">84</td><td style=\"text-align: center;\">0.08</td></tr><tr><td>Day 3</td><td style=\"text-align: center;\">15</td><td style=\"text-align: center;\">61</td><td style=\"text-align: center;\">0.02</td></tr><tr><td>Day 4</td><td style=\"text-align: center;\">3</td><td style=\"text-align: center;\">42</td><td style=\"text-align: center;\">0.01</td></tr></tbody></table><p>When reporting the results, the researchers highlight the difference in viral load after 3 days of treatment with drug X as evidence that the drug is effective.&nbsp; Which of the following raises the most concern about the validity of the study results?</p>",
            "questionHeader": "",
            "explanationText": "<p>This study evaluated the effectiveness of drug X in adult patients hospitalized with a severe viral respiratory tract infection.&nbsp; The results of the study showed a trend toward decreasing viral load in both groups, and the group difference was statistically significant after the second day (eg, <em>p</em>-value &lt;0.05 starting on Day 3).&nbsp; The researchers highlighted that as time progressed, patients receiving drug X had a significantly lower viral load than those receiving standard care.</p><p>However, 18 patients (ie, <strong>46%</strong> of 39 patients) receiving standard care plus <strong>drug X</strong> and 2 patients (ie, <strong>5%</strong> of 39 patients) receiving only <strong>standard care</strong> were not included in the final data analysis due to <strong>death</strong> from cardiopulmonary arrest.&nbsp; This <strong>differential loss to follow-up</strong>&nbsp;is concerning; it may be related to the exposure (ie, drug X), suggesting that drug X may increase the likelihood of death.&nbsp; Differences between the 2 groups are possible but less likely given the randomization process.</p><p>In this case, researchers reported the significant difference in viral load between groups but did not acknowledge the relatively large number of deaths among patients receiving drug X, thus introducing <strong>bias favoring drug X (Choices A and D)</strong>.&nbsp; Differential loss to follow-up is a subtype of selection bias and represents a threat to the internal validity of the study <strong>(Choice E)</strong>.</p><p><strong>(Choice C)</strong>&nbsp; A power analysis was conducted, and the minimum number of patients was estimated at 78, with 39 patients receiving standard care plus drug X and 39 receiving only standard care.&nbsp; Based on this analysis, the study had an adequate sample size for each group.</p><p><strong>Educational objective:</strong><br>Differential loss to follow-up is a subtype of selection bias and represents a threat to the internal validity of a study.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19502,
            "topic": "Study designs",
            "titleId": 19502,
            "title": "Study designs",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decreasing trend in viral load in both groups",
                    "choiceNumber": 1,
                    "correctTaken": 419,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Large number of patients lost to follow-up",
                    "choiceNumber": 2,
                    "correctTaken": 7348,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Small number of patients in each of the 2 groups",
                    "choiceNumber": 3,
                    "correctTaken": 1434,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Statistically insignificant results at Days 0, 1, and 2",
                    "choiceNumber": 4,
                    "correctTaken": 943,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is no concern about the validity of the study results",
                    "choiceNumber": 5,
                    "correctTaken": 444,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 102,
            "othersAvgTimeSpent": 103,
            "notes": null,
            "peopleTaken": 10588,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 741,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 3947,
            "questionIndex": 3947,
            "questionText": "<p>A prospective cohort study was conducted to assess the effects of oral contraceptive (OC) use on the incidence of breast cancer.&nbsp; A crude analysis of the study suggests an association between OC use and breast cancer (relative risk [RR] = 1.40, 95% confidence interval [95%CI]: 1.01, 1.96).&nbsp; Further analysis shows that in women with a family history of breast cancer, OC use increases the risk of breast cancer (RR = 3.33, 95%CI: 2.51, 4.41).&nbsp; In women without a family history of breast cancer, a significantly smaller effect is observed (RR = 1.27, 95%CI: 1.01, 1.60).&nbsp; The results of this study are best explained by which of the following?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"7176\" src=\"https://www.uworld.com/media/L12636.jpg\" ></p><p><strong>Effect modification</strong> (interaction) results when an <strong>extraneous variable</strong> (modifier) <strong>changes</strong> the <strong>direction</strong> or <strong>strength</strong> of an <strong>association</strong> between a risk factor and a disease.&nbsp; A modifier is associated with the disease but not the risk factor.&nbsp; Effect modification can sometimes be confused with confounding, the bias that results when the exposure-disease relationship is obscured by the effect of an extraneous factor (confounder) associated with both exposure and disease.</p><p><strong>Stratified analysis</strong> by the extraneous variable can help distinguish whether that variable is a confounder or an effect modifier, as follows:</p><ul><li><p><strong>Confounder</strong> (left panel):&nbsp; The measures of association (eg, relative risk [RR] of bladder cancer among alcohol users) calculated in each of the stratified groups (eg, smokers and nonsmokers) are similar to one another (eg, nonstatistically significant RR = 0.95 [95%CI: 0.51, 1.76] and RR = 1.03 [95%CI: 0.34, 3.13]), but they differ from the measure of association calculated in the crude analysis (eg, statistically significant RR = 1.81 [95%CI: 1.06, 3.10]); stratification can remove the effects of the confounder (eg, smoking).</p></li><li><p><strong>Effect modifier</strong> (right panel):&nbsp; The measures of association calculated in each of the strata are significantly different (in strength or direction) from one another; stratification can make the effects of the modifier more apparent.</p></li></ul><p>In this example, family history of breast cancer (BC) modifies the association between oral contraceptive (OC) use and BC.&nbsp; Crude analysis reveals a significant association (ie, RR = 1.40 [95%CI: 1.01, 1.96]) between OC use and BC.&nbsp; However, once the association is <strong>stratified</strong> by family history of BC, the <strong>strength</strong> of the association changes (ie, with BC family history, RR = 3.33 [95%CI: 2.51, 4.41]; with no BC family history, RR = 1.27 [95%CI: 1.01, 1.60]), reflecting a significantly higher risk for BC among those who take OCs if they also have a positive BC family history.&nbsp; In other words, positive BC family history acts as an effect modifier.</p><p><strong>(Choice A)</strong>&nbsp; Given that the measures of association are significantly different from one another at the strata level (RR = 3.33 [95%CI: 2.51, 4.41] vs RR = 1.27 [95%CI: 1.01, 1.60]), BC family history is not a confounder.</p><p><strong>(Choice C)</strong>&nbsp; Latency period is the time required for a given exposure to have a measurable effect on the outcome.&nbsp; This study provided no information on how long oral OCs must be used to have an effect on BC risk in susceptible patients.</p><p><strong>(Choices D and E)</strong>&nbsp; Observer bias and selection bias are errors in study design involving misclassification of data and inappropriate selection of participants, respectively.</p><p><strong>Educational objective:</strong><br>Effect modification results when an external variable positively or negatively impacts the effect of a risk factor on the disease of interest.&nbsp; Stratified analysis helps determine whether a variable is a confounder or&nbsp;an effect modifier.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 6409,
            "topic": "Confounding, effect modification, bias, errors",
            "titleId": 6409,
            "title": "Confounding, effect modification, bias, errors",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Confounding bias",
                    "choiceNumber": 1,
                    "correctTaken": 5115,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Effect modification",
                    "choiceNumber": 2,
                    "correctTaken": 7302,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Latency period",
                    "choiceNumber": 3,
                    "correctTaken": 390,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observer bias",
                    "choiceNumber": 4,
                    "correctTaken": 197,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Selection bias",
                    "choiceNumber": 5,
                    "correctTaken": 997,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 102,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 14001,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 635,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 20802,
            "questionIndex": 22304,
            "questionText": "<p>A resident conducts a case-control study to evaluate the association between the use of diuretics and bladder cancer.&nbsp; A sample of 100 patients with bladder cancer is randomly selected from the state cancer registry, and a sample of 100 patients who have been admitted for any reason other than cancer is randomly selected from the resident&#39;s hospital.&nbsp; The resident then evaluates medical charts to determine the frequency of past or current use of diuretics among cases and controls.&nbsp; The results of the study reveal that past or current use of diuretics has a significant protective effect against bladder cancer (odds ratio: 0.75; 95% confidence interval [CI]: 0.67-0.89).&nbsp; The resident&#39;s results contrast with the findings from a population-based study in which the incidence of bladder cancer is equal among those who use diuretics and those who do not (relative risk: 1.01; 95% CI: 0.92-1.25).&nbsp; Which of the following is the most likely explanation for the resident&#39;s study results?</p>",
            "questionHeader": "",
            "explanationText": "<p>This study evaluates the association between diuretic use (exposure) and bladder cancer (outcome).&nbsp; Cases are patients with bladder cancer from a cancer registry, and <strong>controls</strong> are <strong>patients</strong> who were <strong>hospitalized</strong> at a specific hospital for reasons other than cancer.</p><p>Results show that diuretic use is a protective factor against bladder cancer given the odds ratio (OR) = 0.75 (&lt;1), which is statistically significant (95% confidence interval [CI]: 0.67-0.89; does not include the null value OR = 1).&nbsp; However, these results contradict those from a population-based study in which there is no difference in bladder cancer incidence between patients who use diuretics and patients who do not (relative risk: 1.01; 95% CI: 0.92-1.25).&nbsp; This inconsistency may be related to the <strong>frequency of exposure</strong> in the control group.</p><p>Diuretic use is likely more common among hospitalized patients; therefore, a sample of <strong>hospital controls</strong> will likely have a <strong>higher-than-usual frequency of exposure</strong> in this study (ie, control group may not represent target population).&nbsp; As a result, the <strong>measure of association</strong> (eg, OR) is <strong>biased</strong>.&nbsp; The bias is usually toward the null (ie, no association or weaker association); however, in some instances the frequency of the exposure in the control group is so high (compared to the case group) that the direction of the association is reversed, as in this study in which diuretic use was found to have a protective effect (despite having no association with bladder cancer).</p><p>This phenomenon is known an <strong>Berkson bias</strong>&mdash;a type of <strong>selection bias</strong> in which hospitalized controls have a higher frequency of exposure than the general population meant to be represented.</p><p><strong>(Choice A)</strong>&nbsp; Attrition bias refers to an unequal loss of participants from study groups in follow-up (eg, cohort) studies.&nbsp; Case-control studies do not include a follow-up period.</p><p><strong>(Choice B)</strong>&nbsp; Observer bias occurs when the investigator is aware of the exposure status, treatment group, or outcome of the participants and their ability to collect or record the data in an unbiased manner is compromised.</p><p><strong>(Choice C)</strong>&nbsp; Recall bias refers to the inaccurate recollection of past events.&nbsp; It is a potential problem for case-control studies that rely on questionnaires or interviews to collect data about distant past exposure.</p><p><strong>(Choice D)</strong>&nbsp; Response bias occurs when participants in cross-sectional or case-control studies (eg, surveys, polls, questionnaires) purposely give desirable responses to questions about topics perceived to be sensitive (eg, health behaviors).</p><p><strong>Educational objective:</strong><br>Berkson bias is a type of selection bias; it occurs when controls are chosen from among hospitalized patients only, resulting in a potential bias (eg, hospitalized controls may have an exposure related to the outcome of interest) and limiting generalizability.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24175,
            "topic": "Bias",
            "titleId": 24175,
            "title": "Bias",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Attrition bias",
                    "choiceNumber": 1,
                    "correctTaken": 592,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Observer bias",
                    "choiceNumber": 2,
                    "correctTaken": 660,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recall bias",
                    "choiceNumber": 3,
                    "correctTaken": 456,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Response bias",
                    "choiceNumber": 4,
                    "correctTaken": 115,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Selection bias",
                    "choiceNumber": 5,
                    "correctTaken": 8745,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "761,846,true,-1,1*1523,1707,true,-1,1*1720,1887,true,-1,1*2339,2568,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 129,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 10568,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 633,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 18585,
            "questionIndex": 20057,
            "questionText": "<p>A study compares the efficacy of postpartum oral cephalexin in combination with metronidazole versus placebo to decrease surgical site infection rates among women with obesity who have already received standard preoperative antimicrobial prophylaxis and undergone cesarean delivery.&nbsp; The absolute risk reduction between the cephalexin-metronidazole group and the placebo group is 10.0%.&nbsp; In the placebo group, the surgical site infection rate is 16.0%.&nbsp; In the cephalexin-metronidazole group, there are 12 patients with surgical site infection.&nbsp; Based on this information, which of the following is the approximate number of patients in the cephalexin-metronidazole group?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Absolute risk reduction (ARR)</strong> describes the difference in the rate (or risk) of an unfavorable outcome between the treatment group (eg, new treatment) and the control group (eg, standard treatment):</p><div style=\"margin-left: 3em;\"><p><strong>ARR</strong> = (Risk<font size=\"2\"><sub>control</sub></font> &#8722; Risk<font size=\"2\"><sub>treatment</sub></font>)</p></div><p>In this study, <strong>Risk</strong><font size=\"2\"><sub><strong>control</strong></sub></font> is the rate of surgical site infections in the group treated with placebo and Risk<font size=\"2\"><sub>treatment</sub></font> is the rate of surgical site infections in the group treated with cephalexin-metronidazole.&nbsp; It is given that <strong>ARR</strong> = 0.10 (ie, 10%) and <strong>Rate</strong><font size=\"2\"><sub><strong>control</strong></sub></font> is 0.16 (ie, 16%); therefore, the value of Rate<font size=\"2\"><sub>treatment</sub></font> is:</p><div style=\"margin-left: 3em;\"><p><strong>ARR</strong> = Rate<font size=\"2\"><sub>control</sub></font> &ndash; Rate<font size=\"2\"><sub>treatment</sub></font><br>0.10 = 0.16 &ndash; Rate<font size=\"2\"><sub>treatment</sub></font><br>Rate<font size=\"2\"><sub>treatment</sub></font> = 0.16 &#8722; 0.10 = 0.06</p></div><p><strong>Rate</strong><font size=\"2\"><sub><strong>treatment</strong></sub></font> is equal to the number of surgical site <strong>infections</strong> in the cephalexin-metronidazole group <strong>divided</strong> by the <strong>number of patients</strong> in that group (ie, sample size, <em>n</em>).&nbsp; Therefore, it is possible to use the calculated Rate<font size=\"2\"><sub>treatment</sub></font> (ie, 0.06) and the given number of surgical site infections in the cephalexin-metronidazole group (ie, 12) to determine the sample size <em>n</em> of that group as follows:</p><div style=\"margin-left: 3em;\"><p>Rate<font size=\"2\"><sub>treatment</sub></font> = (number of infections) / <em>n</em><br>0.06 = 12 / <em>n</em><br><em><strong>n</strong></em><strong>= 200</strong></p></div><p>The number of patients in the cephalexin-metronidazole group is 200.</p><p><strong>Educational objective:</strong><br>Absolute risk reduction (ARR) describes the difference in the rate (or risk) of an unfavorable outcome between control and treatment groups.&nbsp; It is calculated as follows: ARR = (Rate<font size=\"2\"><sub>control</sub></font> &ndash; Rate<font size=\"2\"><sub>treatment</sub></font>).&nbsp; The rate of an unfavorable outcome is equal to the number of unfavorable outcomes in a group divided by the sample size of that group.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 15391,
            "topic": "Risk, rate, prevalence and incidence",
            "titleId": 15391,
            "title": "Risk, rate, prevalence and incidence",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "60",
                    "choiceNumber": 1,
                    "correctTaken": 808,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "120",
                    "choiceNumber": 2,
                    "correctTaken": 1488,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "160",
                    "choiceNumber": 3,
                    "correctTaken": 902,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "200",
                    "choiceNumber": 4,
                    "correctTaken": 7357,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "400",
                    "choiceNumber": 5,
                    "correctTaken": 101,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 944,
            "othersAvgTimeSpent": 133,
            "notes": null,
            "peopleTaken": 10656,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 720,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 18586,
            "questionIndex": 20058,
            "questionText": "<p>A large, multicenter study was conducted to determine the efficacy of pegfilgrastim, a new drug developed to reduce the risk of febrile neutropenia (FN) in patients with early-stage breast cancer.&nbsp; One thousand women age 40-69 with stage I-III invasive breast carcinoma who were scheduled to receive cyclophosphamide-based chemotherapy were enrolled in the study and randomly assigned to receive either placebo (500 women) or pegfilgrastim (500 women) at a dose previously shown in a small trial to have biological activity.&nbsp; Results showed that the incidence of FN was significantly lower in the pegfilgrastim group than in the placebo group, and that patients in the pegfilgrastim group required fewer hospitalizations and lower antibiotic usage related to FN.&nbsp; Most adverse events were consistent with those expected for breast cancer subjects receiving cyclophosphamide-based chemotherapy.&nbsp; Researchers concluded that pegfilgrastim is safe and significantly reduces the incidence of FN in breast cancer patients.&nbsp; Which of the following best describes this type of study?</p>",
            "questionHeader": "",
            "explanationText": "<p>The clinical trials process addresses whether new treatments (eg, drugs, procedures) are effective and safe for their intended use (eg, treatment of disease) in the target population (eg, patients with the disease of interest).&nbsp; New treatments go through several research phases: some phases involve no human subjects (ie, preclinical studies) <strong>(Choice A)</strong>; and some involve few (ie, phase I and II trials) or many (ie, phase III and IV trials) human subjects.</p><p>A <strong>phase III trial</strong> assesses treatment <strong>efficacy</strong> and human safety (eg, evaluates long-term or rare adverse effects).&nbsp; It compares a <strong>new treatment</strong> to <strong>standard treatments (or placebo)</strong> in a large sample of <strong>affected patients</strong> (ie, patients with the disease of interest).&nbsp; Most phase III trials are <strong>randomized</strong> and <strong>blind</strong> (ie, patients/researchers are unaware of treatment assignment), and may compare <strong>&#8805;2 treatments</strong>.&nbsp; Results determine whether a new treatment is approved by the Food and Drug Administration for a commercial market.</p><p>In this question, the study evaluated the efficacy of a new treatment (ie, pegfilgrastim) in reducing the risk of disease (ie, febrile neutropenia) in affected patients (ie, early-stage breast cancer) who were randomly assigned to the new treatment compared to placebo.&nbsp; This process is consistent with a phase III trial.</p><p><strong>(Choice B)</strong>&nbsp; A phase I trial assesses toxicity, maximum tolerated dose, adverse effects, pharmacokinetics, and pharmacodynamics of a new treatment, usually in a small number of healthy subjects.&nbsp; This study involved a large sample of affected patients and was aimed at assessing efficacy.</p><p><strong>(Choice C)</strong>&nbsp; A phase II trial assesses efficacy, optimal dosing, and adverse effects of a new treatment in a small (rather than a large) number of affected patients (ie, patients with the disease of interest).&nbsp; Some phase II trials may have &#8805;1 group, but these are generally small in sample size.</p><p><strong>(Choice E)</strong>&nbsp; A phase IV trial studies adverse effects caused over time by a new treatment after it has been approved and is on the market, as in a study to assess long-term adverse effects related to use of pegfilgrastim in breast cancer patients.</p><p><strong>Educational objective:</strong><br>Phase III trials evaluate the efficacy, risks, and benefits of a new treatment compared to current standard treatments (or placebo) in a large sample of affected patients (ie, patients with the disease of interest).&nbsp; Most phase III trials are randomized, blind, and compare &#8805;2 treatments.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 28728,
            "topic": "Clinical trials",
            "titleId": 28728,
            "title": "Clinical trials",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Preclinical study",
                    "choiceNumber": 1,
                    "correctTaken": 41,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phase I clinical trial",
                    "choiceNumber": 2,
                    "correctTaken": 408,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phase II clinical trial",
                    "choiceNumber": 3,
                    "correctTaken": 2385,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phase III clinical trial",
                    "choiceNumber": 4,
                    "correctTaken": 7079,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phase IV clinical trial",
                    "choiceNumber": 5,
                    "correctTaken": 824,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "895,1010,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21904102",
                    "mediaDataId": 0,
                    "title": "Key concepts of clinical trials: a narrative review",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21904102",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 115,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 10737,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1785,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 18985,
            "questionIndex": 20466,
            "questionText": "<p>A group of medical geneticists hypothesizes that epidermal growth factor (EGF) could induce colorectal cancer (CRC) cells to undergo epithelial-mesenchymal transition, thereby enhancing their ability to invade and migrate.&nbsp; The group wants to study the relationship between <em>EGF</em> gene polymorphism and CRC.&nbsp; It plans to determine <em>EGF</em> A61G polymorphism by using PCR-restriction fragment length polymorphism method in 249 patients diagnosed with CRC and in 261 patients without a diagnosis of CRC.&nbsp; Which of the following is the most appropriate null hypothesis for this study?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"6804\" src=\"https://www.uworld.com/media/L13767.jpg\" ></p><p>A statistical hypothesis is an initial assumption, which may or may not be true, regarding population parameters (eg, mean values in two different groups) or the relationship between variables within a population (eg, association between an exposure and a disease).&nbsp; The <strong>null hypothesis (H<font size=\"2\"><sub>0</sub></font>)</strong> is a statement of no difference or <strong>no association</strong>.&nbsp; The alternative hypothesis (H<font size=\"2\"><sub>a</sub></font>) is a statement of difference or association.</p><p>In this case, patients are <strong>initially identified</strong> based on their <strong>disease status</strong> (ie, cases: patients with colorectal cancer [CRC]; controls: patients without CRC).&nbsp; The <strong>frequency of exposure</strong> (ie, epidermal growth factor [EGF] A61G polymorphism) is <strong>subsequently compared</strong> between cases and controls.&nbsp; Therefore, this is a <strong>case-control study</strong>.&nbsp; The most appropriate measure of association between an exposure and a disease in case-control studies is the <strong>odds ratio (OR)</strong>, which represents the odds of exposure among cases relative to controls.</p><p>The OR may be interpreted as follows:</p><ul><li><p><strong>OR = 1.0 (null value)</strong> indicates that the odds of exposure among cases are the same as the odds of exposure among controls; therefore, <strong>exposure is not associated with the disease</strong>.</p></li><li><p>OR &#8800; 1.0 indicates that the odds of exposure among cases are lower (ie, OR &lt;1) or higher (ie, OR &gt;1) than among controls; therefore, exposure is associated with the disease.</p></li></ul><p>The OR is sometimes described as the odds of disease among exposed patients relative to nonexposed patients; these two OR definitions are mathematically equivalent.</p><p>Because H<font size=\"2\"><sub>0</sub></font> is a statement of no association, the most appropriate H<font size=\"2\"><sub>0</sub></font> for the study is that the OR = 1 <strong>(Choice D)</strong>.</p><p><strong>(Choices A, B, E, and F)</strong>&nbsp; Measures of association based on risk/incidence, such as relative risk and hazard ratio (eg, used in comparing 2 Kaplan-Meier survival curves), are calculated in cohort studies and experimental designs.&nbsp; In such designs, participants are initially selected based on exposure status (ie, exposed or nonexposed to a risk factor or treatment) and then followed over time to assess development of disease.&nbsp; By contrast, in case-control studies, cases (by definition) already have the disease.&nbsp; Therefore, case-control studies cannot calculate and compare the risk/incidence of disease between the case and control groups; instead, they must compare the odds of exposure (to a risk factor) between cases and controls.</p><p><strong>Educational objective:</strong><br>The odds ratio (OR) is a measure of association used in case-control studies.&nbsp; It quantifies the relationship between an exposure and a disease; its null value (ie, null hypothesis) is always 1 (ie, OR = 1).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 5925,
            "topic": "Case control studies",
            "titleId": 5925,
            "title": "Case control studies",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Hazard ratio is equal to 1",
                    "choiceNumber": 1,
                    "correctTaken": 621,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hazard ratio is not equal to 1",
                    "choiceNumber": 2,
                    "correctTaken": 181,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Odds ratio is equal to 1",
                    "choiceNumber": 3,
                    "correctTaken": 6734,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Odds ratio is not equal to 1",
                    "choiceNumber": 4,
                    "correctTaken": 772,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Relative risk is equal to 1",
                    "choiceNumber": 5,
                    "correctTaken": 1878,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Relative risk is not equal to 1",
                    "choiceNumber": 6,
                    "correctTaken": 413,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1744,1890,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 102,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 10599,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 354,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 20824,
            "questionIndex": 22326,
            "questionText": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:100%;\"><tbody><tr><td id=\"vignettedescriptor\">The drug advertisement in the exhibit button applies to the next <strong>2</strong> items.&nbsp;</td></tr></tbody></table><p>A 24-year-old woman is hospitalized for lupus nephritis.&nbsp; She has had multiple hospitalizations in the past for nephritis.&nbsp; She speaks with her nephrologist about promotional material from a pharmaceutical company that conducted a randomized, placebo-controlled trial for a monoclonal antibody, LupMAB, in the treatment of patients with lupus nephritis.&nbsp; The trial compared LupMAB + standard therapy to standard therapy alone.</p><p><strong>Item 1 of 2</strong></p><p>Which of the following most likely represents the odds ratio and 95% confidence interval of achieving a renal response among patients who received LupMAB + standard therapy compared to those who received standard therapy alone?</p>",
            "questionHeader": "",
            "explanationText": "<p>This study compared the efficacy of LupMAB (a monoclonal antibody) + standard therapy (either mycophenolate mofetil [MMF] or cyclophosphamide-azathioprine [CA]) to standard therapy alone for lupus nephritis.&nbsp; The primary outcome of the study was renal response evaluated at 6-week intervals.&nbsp; Results showed that patients who received <strong>LupMAB + standard therapy</strong> had <strong>55% greater odds</strong> of <strong>renal response</strong> compared to patients who received standard therapy alone.</p><p>The <strong>odds ratio (OR)</strong> is a measure of association between an exposure to a risk factor and an outcome.&nbsp; OR is usually defined as the odds of an exposure in cases divided by the odds of the same exposure in controls.&nbsp; However, it may also be defined as the <strong>odds of disease among exposed</strong> patients (eg, treatment group) <strong>relative to nonexposed patients</strong> (eg, control group).&nbsp; These two OR definitions are mathematically equivalent.</p><p style=\"text-align: center;\">OR = (odds of disease in treatment group) / (odds of disease in control group)</p><p>A value of <strong>OR &gt; 1.0</strong> indicates that the exposure (eg, treatment) is associated with an <strong>increase in odds of outcome</strong>.&nbsp; Because the odds of renal response in the treatment group (ie, LupMAB + standard therapy) is 55% greater compared to the control group (standard therapy alone), <strong>OR = 1.55</strong> (ie, 155%) <strong>(Choices C and D)</strong>.</p><p>The <strong>confidence interval (CI)</strong> of an OR indicates, with a certain confidence level, whether a given OR is statistically different from the null value (ie, OR = 1.0).&nbsp; A CI that <strong>excludes the null value</strong> is statistically significant (at that confidence level).&nbsp; A result that is <strong>statistically significant</strong> based on the 95% CI would also be statistically significant based on a value of <em>p</em> &lt; 0.05.&nbsp; In this trial, given that the renal response rate between groups was statistically significant (43% vs 32%; <em><strong>p</strong></em>&nbsp;<strong>= 0.031</strong>), the 95% CI must not contain the null value (ie, OR = 1.0) <strong>(Choice F)</strong>.&nbsp; Therefore, the OR in this study is likely 1.55 with a <strong>95% CI (1.01-2.31)</strong>.</p><p><strong>(Choices A and B)</strong>&nbsp; A value of OR &lt; 1 (eg, OR = 0.45) indicates that the exposure (eg, treatment) is associated with a decrease in the odds of the outcome.&nbsp; In this case, an OR = 0.45 indicates that there is a 1 &#8722; 0.45 = 0.55 (or 55%) lower odds of the outcome, but the promotional material states that the treatment was associated with greater odds of the outcome.</p><p><strong>Educational objective:</strong><br>An odds ratio (OR) value of OR &gt; 1 indicates that the exposure (eg, treatment) is associated with an increase in odds of an outcome.&nbsp; A confidence interval that excludes the null value (ie, OR = 1.0) is statistically significant.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 24197,
            "topic": "Statistical vs. clinical significance",
            "titleId": 24197,
            "title": "Statistical vs. clinical significance",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 20824,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 1,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "0.45 (0.31-1.10)",
                    "choiceNumber": 1,
                    "correctTaken": 291,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "0.45 (0.28-0.83)",
                    "choiceNumber": 2,
                    "correctTaken": 1603,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "1.22 (0.95-1.50)",
                    "choiceNumber": 3,
                    "correctTaken": 906,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "1.22 (1.11-1.33)",
                    "choiceNumber": 4,
                    "correctTaken": 2768,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "1.55 (1.01-2.31)",
                    "choiceNumber": 5,
                    "correctTaken": 5612,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "1.55 (0.91-2.19)",
                    "choiceNumber": 6,
                    "correctTaken": 511,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 2,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": {
                "id": 51170,
                "fileName": "L78561.png",
                "typeId": 1,
                "title": "Pharm AD",
                "sequenceId": 1,
                "active": true,
                "baseUrl": "https://apps.uworld.com/media/"
            },
            "timeSpent": 572,
            "othersAvgTimeSpent": 163,
            "notes": null,
            "peopleTaken": 11691,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 452,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 20825,
            "questionIndex": 22327,
            "questionText": "<p><strong>Item 2 of 2</strong></p><p>The patient asks the physician whether LupMAB-based therapy is recommended.&nbsp; Based on the promotional material, which of the following is the best response to this patient&#39;s inquiry?</p>",
            "questionHeader": "",
            "explanationText": "<p>Study results showed that 43% of patients receiving LupMAB + standard therapy achieved renal response compared to 32% of patients receiving standard therapy alone, with a statistically significant result given the value <em>p</em> &lt; 0.05.&nbsp; This translates into an <strong>absolute difference of 11%</strong> (43 &#8722; 32 = 11%).</p><p>The relative difference of (43 &#8722; 32) / 32 = 34% is greater than the absolute difference.&nbsp; For this reason, journal articles and promotional materials often prefer to show the relative difference to emphasize the positive effect of the drug; however, absolute measures generally provide a more realistic idea of the true impact.&nbsp; Similarly, highlighting the odds of 55% makes the effect appear more pronounced.</p><p><strong>(Choice A)</strong>&nbsp; This study compared the efficacy of a combined therapy (ie, LupMAB in combination with standard therapy) to standard therapy alone; therefore, it is not possible to determine the efficacy of LupMAB as a monotherapy to treat lupus nephritis.</p><p><strong>(Choice B)</strong>&nbsp; Subgroup analyses showed that, compared with placebo, more patients receiving LupMAB + mycophenolate mofetil (MMF) achieved renal response with a statistically significant result.&nbsp; Similarly, more patients receiving LupMAB + cyclophosphamide-azathioprine (CA) achieved renal response, but the difference was not statistically significant.&nbsp; The CA subgroup was smaller (eg, larger sample may have shown statistical significance) and had a greater proportion of patients with more advanced renal disease at baseline, raising the possibility that advanced disease (rather than CA treatment) affects response to LupMAB therapy.&nbsp; Because of the smaller sample size, the differences in disease severity, and the lack of detailed information regarding prior treatment plans, offering specific recommendations based on subgroup analyses would be suboptimal.</p><p><strong>(Choice D)</strong>&nbsp; A study may be powered to detect differences in some effects but not others.&nbsp; This study showed a statistically significant difference in odds of renal response, indicating that it had the power (ie, it was not underpowered) to detect such a result.&nbsp; The frequency of adverse drug events, including low numbers of death events, was not statistically different between the intervention and the placebo groups, which may or may not reflect sufficient power to detect such differences; however, this provides no information on the power to detect a difference in odds of renal response.</p><p><strong>(Choice E)</strong>&nbsp; A confidence interval for the odds ratio is not necessary because the <em>p</em>-value already established that the difference in renal response between groups is statistically significant.</p><p><strong>Educational objective:</strong><br>Journal articles and promotional material may highlight relative measures to emphasize the positive effect of an intervention.&nbsp; However, absolute measures generally provide a more realistic idea of true impact.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 30875,
            "topic": "Evidence-based clinical recommendations",
            "titleId": 30875,
            "title": "Evidence-based clinical recommendations",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 20824,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 2,
            "questionSetCount": 2,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "LupMAB 5 mg/kg can be recommended as monotherapy based on the results of this study",
                    "choiceNumber": 1,
                    "correctTaken": 605,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "LupMAB 5 mg/kg + standard therapy can be recommended but only if she was previously treated with MMF rather than CA",
                    "choiceNumber": 2,
                    "correctTaken": 4470,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "LupMAB 5 mg/kg + standard therapy can be recommended but the absolute difference in renal response compared to standard therapy alone is likely lower than 55%",
                    "choiceNumber": 3,
                    "correctTaken": 5622,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "LupMAB 5 mg/kg should not be recommended because the low numbers of death events suggests that the study was underpowered to show a significant difference in odds of renal response",
                    "choiceNumber": 4,
                    "correctTaken": 387,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "LupMAB 5 mg/kg should not be recommended because the statistical significance of the results at week 90 cannot be determined without a confidence interval",
                    "choiceNumber": 5,
                    "correctTaken": 618,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 2,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": {
                "id": 51170,
                "fileName": "L78561.png",
                "typeId": 1,
                "title": "Pharm AD",
                "sequenceId": 1,
                "active": true,
                "baseUrl": "https://apps.uworld.com/media/"
            },
            "timeSpent": 372,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 11702,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 639,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 40,
            "questionId": 19019,
            "questionIndex": 20502,
            "questionText": "<p>A large study is conducted to assess the association between altitude and life expectancy.&nbsp; Researchers obtained data on life expectancy at the county level from the Centers for Disease Control and Prevention and collected altitude data from the US Geological Survey.&nbsp; A regression was used to model the association between altitude and life expectancy at the county level in 3,064 counties in the contiguous US while also controlling for several well-established covariates.&nbsp; Which of the following best describes the design of this study?</p>",
            "questionHeader": "",
            "explanationText": "<p>In this study, researchers collected:</p><ul><li><strong>county-level data</strong> on life expectancy from the Centers for Disease Control and Prevention and</li></ul><ul><li>altitude data from the US Geological Survey</li></ul><p>to determine whether altitude is associated with life expectancy.</p><p>Using <strong>population-level</strong> (eg, county, state, country), rather than individual-level, data as a unit of analysis in such a manner is consistent with an <strong>ecological study</strong>.&nbsp; Ecological studies are useful for generating hypotheses but should not be used to draw conclusions regarding individuals within these populations because statistical relationships observed in a population (ie, a collection of individuals) may not hold true within all of the subgroups that make up that population.</p><p>For example, this study may show that altitude is significantly associated with longer life expectancy at the county level when, in fact, altitude is significantly associated with shorter life expectancy in certain groups within a county (eg, people with chronic obstructive pulmonary disease).&nbsp; This apparent paradox is known as <strong>ecological fallacy</strong>.</p><p><strong>(Choices A and B)</strong>&nbsp; Cohort and cross-sectional studies deal with <em>individuals</em> rather than populations.&nbsp; In cohort studies, individuals with and without different exposures (eg, residing in high- or low-altitude locations) are followed over time to compare outcomes (eg, life expectancy).&nbsp; In cross-sectional studies, individuals are assessed for exposure to risk factors and disease simultaneously at a given point in time (&#x22;snapshot&#x22;) to determine whether risk factors are associated with disease (at the individual level).&nbsp; The overall design of this multicounty study relies on population-level data, not individual-level data.</p><p><strong>(Choice D)</strong>&nbsp; Qualitative studies use focus groups, interviews (structured and semi-structured), and other anthropologic techniques to obtain narrative information for explaining quantitative results.</p><p><strong>(Choice E)</strong>&nbsp; Systematic reviews and meta-analyses combine the results of several published studies (with an emphasis on high-quality, randomized controlled studies) to estimate the pooled effect.</p><p><strong>Educational objective:</strong><br>In ecological studies, the unit of observation is the population, not the individual.&nbsp; Disease rates and exposures are measured in each of a series of populations and their associations determined.&nbsp; Results about associations at the population level may not translate to the individual level.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 216,
            "system": "Biostatistics & Epidemiology",
            "topicId": 19502,
            "topic": "Study designs",
            "titleId": 19502,
            "title": "Study designs",
            "topicAttributeId": 330673,
            "topicAttribute": "Study design and interpretation",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cohort study",
                    "choiceNumber": 1,
                    "correctTaken": 550,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cross-sectional survey",
                    "choiceNumber": 2,
                    "correctTaken": 2214,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ecological study",
                    "choiceNumber": 3,
                    "correctTaken": 7203,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Qualitative study",
                    "choiceNumber": 4,
                    "correctTaken": 286,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Systematic review",
                    "choiceNumber": 5,
                    "correctTaken": 335,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1745,1931,true,-1,1*1944,2125,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 59,
            "othersAvgTimeSpent": 48,
            "notes": null,
            "peopleTaken": 10588,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 500,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": [
        {
            "id": 3769,
            "title": "",
            "header": null,
            "text": "<p><u><strong>Title</strong></u></p>\n\n<p>Alcohol, smoking, and caffeine in relation to fecundability and NAT2</p>\n\n<p><u><strong>Objective</strong></u></p>\n\n<p>To investigate how alcohol, smoking, and caffeine associate with fecundability and determine whether the most common polymorphisms in the N-acetyltransferase 2 (NAT2) metabolic enzyme help explain these associations.</p>\n\n<p><u><strong>Methods</strong></u></p>\n\n<p><em>Design:</em>&nbsp; Prospective study of fertility and menstrual function.&nbsp; Follow-up for an average of eight menstrual cycles.</p>\n\n<p><em>Participants:</em>&nbsp; 295 women age 20-41 at risk for pregnancy.</p>\n\n<p><em>Exposure:</em>&nbsp; Caffeine categorized into mean caffeine intake &lt;300 mg/day and &ge;300 mg/day.&nbsp; Alcohol categorized into &lt;1 drink/day and &ge;1 drinks/day.&nbsp; Smoking categorized into smokers and nonsmokers.&nbsp; NAT2 acetylator status categorized into slow and rapid NAT2 acetylator phenotypes.</p>\n\n<p><em>Outcome:</em>&nbsp; Fecundability.</p>\n\n<p><u><strong>Results</strong></u></p>\n\n<p>In general, fecundability was not associated with caffeine (odds ratio [OR] = 0.89; 95% confidence interval [CI]: 0.58 to 1.38) or current smoking (OR = 1.04; 95% CI: 0.65 to 1.67).&nbsp; Alcohol use was significantly associated with reduced fecundability (OR = 0.50; 95% CI: 0.28 to 0.89).&nbsp; However, the associations were inconsistent across NAT2 status.&nbsp; NAT2 status alone was not significantly associated with fecundability (OR = 1.44; 95% CI: 0.89 to 2.35).</p>\n\n<p><img draggable=\"false\" id=\"44658\" src=\"https://www.uworld.com/media/L70114.png\" /></p>\n\n<p><u><strong>Conclusion</strong></u></p>\n\n<p>This research suggests the need to incorporate genetic information about metabolic enzymes to better interpret and understand the effects of xenobiotics on human health.</p>",
            "difficultyLevelId": 0,
            "poolTypeId": 1,
            "categoryTypeId": 0,
            "abstractAdoptedFrom": "",
            "source": null,
            "sourceLink": null,
            "vocabularyList": null,
            "qbankId": 2,
            "footnotesList": null,
            "abstractCitation": null,
            "passagePreviewList": null,
            "annotations": null
        },
        {
            "id": 3893,
            "title": "",
            "header": null,
            "text": "<p><u><strong>Title</strong></u></p><p>Postoperative acute renal failure (ARF) in pediatric patients undergoing cardiopulmonary bypass (CPB).</p><p><u><strong>Objective</strong></u></p><p>To identify risk factors associated with postoperative ARF according to the Pediatric Risk, Injury, Failure, Loss, End-Stage Renal Disease (pRIFLE) scale in children undergoing cardiac surgery with CPB.</p><p><u><strong>Methods</strong></u></p><p><em>Design:</em>&nbsp; Case-control study.</p><p><em>Participants:</em>&nbsp; 455 children age &lt;16 who were admitted to the pediatric intensive care unit after cardiac surgery that required CPB.&nbsp; Cases were patients who developed some degree of ARF according to pRIFLE criteria (<em>n</em> = 155); controls were patients who did not develop ARF (<em>n</em> = 300).</p><p><em>Exposure:</em>&nbsp; Cardiac surgery requiring CPB.</p><p><em>Outcome:</em>&nbsp; Pediatric postoperative ARF.</p><p><u><strong>Results</strong></u></p><p>Bivariate and multivariate analyses (adjusted for age, sex, and CPB duration) are shown below.</p><div id=\"div_T69592\"><table class=\"table-default-style table-footer-only-style\" style=\"width:100.0%\"><tbody><tr><td rowspan=\"2\" style=\"width:46.0%;\"><p align=\"center\"><strong>Factor</strong></p></td><td colspan=\"2\" style=\"width:27.0%;\"><p align=\"center\"><strong>Acute renal failure</strong></p></td></tr><tr><td style=\"width:27.0%;\"><p align=\"center\"><strong>Bivariate* OR<br />(95% CI)</strong></p></td><td style=\"width:27.0%;\"><p align=\"center\"><strong>Multivariate** OR<br />(95% CI)</strong></p></td></tr><tr><td style=\"width:46.0%\"><p><em>Aortic clamping</em></p><p>&nbsp; &nbsp; No</p><p>&nbsp; &nbsp; Yes</p></td><td style=\"width:27.0%\">&nbsp;<p align=\"center\">&ndash;</p><p align=\"center\">1.32 (1.27-1.95)</p></td><td style=\"width:27.0%\">&nbsp;<p align=\"center\">&ndash;</p><p align=\"center\">1.08 (0.51-1.26)</p></td></tr><tr><td style=\"width:46.0%\"><p><em>Duration of CPB</em></p><p>&nbsp; &nbsp; &lt;139.9 min</p><p>&nbsp; &nbsp; &ge;140 min</p></td><td style=\"width:27.0%\">&nbsp;<p align=\"center\">&ndash;</p><p align=\"center\">11.84 (2.45-30.72)</p></td><td style=\"width:27.0%\">&nbsp;<p align=\"center\">&ndash;</p><p align=\"center\">7.47 (0.91-16.84)</p></td></tr><tr><td style=\"width:46.0%\"><p><em>Low cardiac output syndrome</em></p><p>&nbsp; &nbsp; No</p><p>&nbsp; &nbsp; Yes</p></td><td style=\"width:27.0%\">&nbsp;<p align=\"center\">&ndash;</p><p align=\"center\">1.57 (1.34-1.84)</p></td><td style=\"width:27.0%\">&nbsp;<p align=\"center\">&ndash;</p><p align=\"center\">1.04 (0.29-1.15)</p></td></tr><tr><td style=\"width:46.0%\"><p><em>Maximal hyperlactatemia during CPB</em></p><p>&nbsp; &nbsp; Mild (3-5 mmol/L)</p><p>&nbsp; &nbsp; Moderate to severe (&ge;6 mmol/L)</p></td><td style=\"width:27.0%\">&nbsp;<p align=\"center\">&ndash;</p><p align=\"center\">8.7 (3.69-37.24)</p></td><td style=\"width:27.0%\">&nbsp;<p align=\"center\">&ndash;</p><p align=\"center\">4.91 (1.26-19.05)</p></td></tr><tr><td style=\"width:46.0%\"><p><em>Metabolic acidosis</em></p><p>&nbsp; &nbsp; Mild</p><p>&nbsp; &nbsp; Moderate</p><p>&nbsp; &nbsp; Severe</p></td><td style=\"width:27.0%\">&nbsp;<p align=\"center\">&ndash;</p><p align=\"center\">2.63 (1.04-10.95)</p><p align=\"center\">6.70 (1.67-26.82)</p></td><td style=\"width:27.0%\">&nbsp;<p align=\"center\">&ndash;</p><p align=\"center\">1.98 (0.27-8.21)</p><p align=\"center\">4.01 (0.84-17.41)</p></td></tr><tr><td style=\"width:46.0%\"><p><em>Type of heart disease</em></p><p>&nbsp; &nbsp; Acyanotic</p><p>&nbsp; &nbsp; Cyanotic</p></td><td style=\"width:27.0%\">&nbsp;<p align=\"center\">&ndash;</p><p align=\"center\">5.8 (2.08-16.3)</p></td><td style=\"width:27.0%\">&nbsp;<p align=\"center\">&ndash;</p><p align=\"center\">3.62 (1.11-11.63)</p></td></tr><tr><td colspan=\"3\" style=\"width:27.0%;\"><p>*Unadjusted analysis.</p><p>**Adjusted for age, sex &amp; duration of CPB.</p><p><strong>CI</strong> = confidence interval; <strong>CPB</strong> = cardiopulmonary bypass; <strong>OR</strong> = odds ratio.</p></td></tr></tbody></table></div><p><u><strong>Conclusion</strong></u></p><p>The study identified several independent risk factors associated with the development of postsurgical ARF.</p>",
            "difficultyLevelId": 0,
            "poolTypeId": 1,
            "categoryTypeId": 0,
            "abstractAdoptedFrom": "",
            "source": null,
            "sourceLink": null,
            "vocabularyList": null,
            "qbankId": 2,
            "footnotesList": null,
            "abstractCitation": null,
            "passagePreviewList": null,
            "annotations": null
        },
        {
            "id": 3942,
            "title": "",
            "header": null,
            "text": "<p><u><strong>Objective</strong></u></p><p>To compare the effects of a brown rice&ndash;based vegan diet to a standard diabetic diet on glycemic control.</p><p><u><strong>Methods</strong></u></p><p><em>Design:</em>&nbsp; Open, randomized controlled trial without participant blinding.</p><p><em>Follow-up period:</em>&nbsp; 0, 12 weeks.</p><p><em>Participants:</em>&nbsp; 118 patients with type 2 diabetes mellitus.&nbsp; Inclusion criteria: age 30-70; taking oral antidiabetic agents for &ge;6 months; hemoglobin A1c (HbA1c) level of 6%-10%.&nbsp; Exclusion criteria: increase in dose of antidiabetic agent or addition of new antidiabetic agent in past 3 months.</p><p><em>Intervention:</em>&nbsp; Vegan diet (<em>n</em> = 59) versus standard diabetic diet (<em>n</em> = 59) for 12 weeks.&nbsp; Compliance reported based on a self-assessment daily dietary record allowing standardized conversion to a percentage scale.</p><p><em>Outcomes:</em>&nbsp; Primary endpoints: change in HbA1c level over 12 weeks.&nbsp; Secondary endpoints include change in BMI and in waist circumference.</p><p><u><strong>Results</strong></u></p><p>An excerpt of results for Week 0, Week 12, and Change (Week 12 &minus; Week 0) is shown below.</p><div id=\"div_T69543\"><table class=\"table-default-style table-footer-only-style\" style=\"width:100.0%\"><tbody><tr><td style=\"width:22.0%\"></td><td colspan=\"3\" style=\"width:13.0%\"><p align=\"center\"><strong>Vegan diet (<em>n</em> = 59)</strong></p></td><td colspan=\"3\" style=\"width:13.0%\"><p align=\"center\"><strong>Standard diabetic diet (<em>n</em> = 59)</strong></p></td></tr><tr><td style=\"width:22.0%\"></td><td style=\"width:13.0%\"><p align=\"center\">Week 0</p></td><td style=\"width:13.0%\"><p align=\"center\">Week 12</p></td><td style=\"width:13.0%\"><p align=\"center\">Change<br />(Week 12 &minus; Week 0)</p></td><td style=\"width:13.0%\"><p align=\"center\">Week 0</p></td><td style=\"width:13.0%\"><p align=\"center\">Week 12</p></td><td style=\"width:13.0%\"><p align=\"center\">Change<br />(Week 12 &minus; Week 0)</p></td></tr><tr><td colspan=\"7\" style=\"width:13.0%\"><p><strong>Primary endpoint*</strong></p></td></tr><tr><td style=\"width:22.0%\"><p align=\"center\">HbA1c (%), all participants</p></td><td style=\"width:13.0%\"><p align=\"center\">7.7 &plusmn; 1.3</p></td><td style=\"width:13.0%\"><p align=\"center\">7.1 &plusmn; 1.3</p></td><td style=\"width:13.0%\"><p align=\"center\">&minus;0.5 &plusmn; 0.8**</p></td><td style=\"width:13.0%\"><p align=\"center\">7.4 &plusmn; 1.0</p></td><td style=\"width:13.0%\"><p align=\"center\">7.2 &plusmn; 0.9</p></td><td style=\"width:13.0%\"><p align=\"center\">&minus;0.2 &plusmn; 0.7**</p></td></tr><tr><td style=\"width:22.0%\"><p align=\"center\">HbA1c (%), participants with &ge;90% compliance<br />(<em>n</em> = 15 in vegan,<br /><em>n</em> = 56 in diabetic)</p></td><td style=\"width:13.0%\"><p align=\"center\">7.2 &plusmn; 1.2</p></td><td style=\"width:13.0%\"><p align=\"center\">6.6 &plusmn; 0.9</p></td><td style=\"width:13.0%\"><p align=\"center\">&minus;0.9 &plusmn; 0.8**</p></td><td style=\"width:13.0%\"><p align=\"center\">7.4 &plusmn; 1.1</p></td><td style=\"width:13.0%\"><p align=\"center\">7.2 &plusmn; 1.0</p></td><td style=\"width:13.0%\"><p align=\"center\">&minus;0.3 &plusmn; 0.7**</p></td></tr><tr><td colspan=\"7\" style=\"width:13.0%\"><p><strong>Secondary endpoints*</strong></p></td></tr><tr><td style=\"width:22.0%\"><p align=\"center\">BMI (kg/m<sup>2</sup>)</p></td><td style=\"width:13.0%\"><p align=\"center\">23.9 &plusmn; 3.4</p></td><td style=\"width:13.0%\"><p align=\"center\">23.5 &plusmn; 3.4</p></td><td style=\"width:13.0%\"><p align=\"center\">&minus;0.5 &plusmn; 0.9**</p></td><td style=\"width:13.0%\"><p align=\"center\">23.1 &plusmn; 2.4</p></td><td style=\"width:13.0%\"><p align=\"center\">23.0 &plusmn; 2.4</p></td><td style=\"width:13.0%\"><p align=\"center\">&minus;0.1 &plusmn; 0.6</p></td></tr><tr><td style=\"width:22.0%\"><p align=\"center\">Waist circumference (cm)</p></td><td style=\"width:13.0%\"><p align=\"center\">84.0 &plusmn; 9.8</p></td><td style=\"width:13.0%\"><p align=\"center\">81.9 &plusmn; 9.9</p></td><td style=\"width:13.0%\"><p align=\"center\">&minus;3.1 &plusmn; 4.9**</p></td><td style=\"width:13.0%\"><p align=\"center\">82.3 &plusmn; 7.5</p></td><td style=\"width:13.0%\"><p align=\"center\">81.5 &plusmn; 7.9</p></td><td style=\"width:13.0%\"><p align=\"center\">&minus;0.8 &plusmn; 4.6</p></td></tr><tr><td colspan=\"7\" style=\"width:13.0%\"><p>*Values represent means &plusmn; standard deviations.&nbsp; The <em>p</em>-values for tests comparing the mean change in primary endpoint between the 2 diet groups were statistically significant regardless of compliance.</p><p><em>**p</em> &lt; 0.01; <em>p</em>-values for paired <em>t-</em>test to determine whether changes from Week 0 to Week 12 are significantly different from 0.</p></td></tr></tbody></table></div>",
            "difficultyLevelId": 0,
            "poolTypeId": 1,
            "categoryTypeId": 0,
            "abstractAdoptedFrom": "",
            "source": null,
            "sourceLink": null,
            "vocabularyList": null,
            "qbankId": 2,
            "footnotesList": null,
            "abstractCitation": null,
            "passagePreviewList": null,
            "annotations": null
        }
    ],
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}